Syracuse University

SURFACE at Syracuse University
Dissertations - ALL

SURFACE at Syracuse University

Summer 7-16-2021

Development of Computational Antibiotic Screening Platform
Across Bacterial Outer Membrane Proteins
Yinghui Dai
Syracuse University

Follow this and additional works at: https://surface.syr.edu/etd
Part of the Chemical Engineering Commons

Recommended Citation
Dai, Yinghui, "Development of Computational Antibiotic Screening Platform Across Bacterial Outer
Membrane Proteins" (2021). Dissertations - ALL. 1450.
https://surface.syr.edu/etd/1450

This Dissertation is brought to you for free and open access by the SURFACE at Syracuse University at SURFACE at
Syracuse University. It has been accepted for inclusion in Dissertations - ALL by an authorized administrator of
SURFACE at Syracuse University. For more information, please contact surface@syr.edu.

Abstract
Antibiotics are medicines used to treat bacterial infections by either killing bacteria or
stopping them from reproducing. Throughout the use of antibiotics, bacteria has developed a
variety of defense mechanisms against antibiotics and thus diminishing their effectiveness.

Antibiotic resistance is a growing threat and becomes a global crisis as it is able to constantly
evolve and rapidly spread. In the face of increasing bacterial resistance to all known antibiotics,
there is an urgent need to accelerate the antibiotic discovery pipeline and discover new classes of
antibiotics. A major bottleneck in the discovery of novel antibiotics is the limited permeability of
potent drug molecules across the bacterial envelope to reach their target, and thus hindering their
activities in vivo. With the aid of state-of-the-art computational methods and tools, we developed

a computational platform to automate and study the translocation of small molecule drugs across
bacterial outer membrane proteins, with a goal of accelerating the antibiotic discovery process. We
applied all-atom and coarse-grained molecular modeling, enhanced sampling techniques, and a
parallel computing environment to maximize the performance. We further demonstrate the
efficacy of this platform with a comprehensive study of a benchmark case. Key findings include
free energy profile, translocation kinetics and thermodynamics, and molecular interactions

between drug molecules and protein residues. Ultimately, this approach is designed to screen small
molecule libraries with a fast turnaround time to yield structure-property relationships to discover
antibiotics with high permeability. Furthermore, this work is expected to provide insights in
inverse engineering and mutation design during drug development.
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CHAPTER 1.
INTRODUCTION

1

1.1 Background
Antibiotics are medicines used to treat bacterial infections by either killing the bacteria or
slowing down their reproduction. Throughout the use of antibiotics, bacteria has developed
different resistance mechanisms to fight against anti-infective drugs (Figure 1-1).1 There are many
defense strategies, including but not limited to, producing pumps to get rid of antibiotics,
developing protein channels with low permeability to restrict access, destroying or modifying
drugs with enzymes, mutating target structure to prevent the binding of antibiotics, and expressing
alternative proteins required for cell functions. 1-2

Figure 1-1 Antibiotic resistance strategies in bacteria
Antibiotic resistant germs are able to quickly spread everywhere considering the fact that
they are very small living organisms and they constantly evolve at a staggering rate. A variety of
factors have mixed and exacerbated the antimicrobial resistance. They spread within and across
all settings in the community that are associated with the entire environment. Moreover, antibiotic
resistance is rapidly spreading all over the world due to overprescription and misuse of drugs. For
example, there is a large-scale of antibiotic consumption in agriculture and livestock farming, and

2

animals that carry drug resistant pathogens will consequently contaminate the food supply. The
antibiotic resistance is endangering both individual and society. It has been reported that there are
approximately 3 million people in the United States infected by antibiotic resistant pathogens every
year, leading to more than 35000 deaths. 2-3
In addition to the rapid spreading, stranded discovery pipeline has become exhausted. The
drug discovery pipeline is at a virtual standstill due to limited profits and regulatory bottlenecks.
It is estimated that over $1 billion is needed for developing an antibiotic. 3 As a result, many
pharmaceutical companies have abandoned the antibiotic discovery market in favor of pursuing
more profitable drug discovery line, such as cancer drugs. Infectious diseases are now on the verge
of acquiring effective treatments using novel antibiotics. Antibiotic discovery requires
revolutionary methodology to accelerate the process and reduce overall costs.
One of the bottlenecks in antibiotic discovery is to overcome the inability of drug
candidates to penetrate through bacterial membrane to eventually reach their target.3 Comparing
to Gram-positive bacteria, Gram-negative bacteria has developed liposaccharide-rich, negatively
charged outermembrane, which serves as a highly effective barrier against most small molecule
drugs. In addition, a variety of size-selective, substrate-specific protein channels (or porins) are
expressed, which are embedded in the outermembrane to further decrease the uptake (Figure 12).4 Understanding the porin facilitated translocation of small molecules at a molecular scale is
particularly imperative to drug discovery.
In our work, we focused on Pseudomonas aeruginosa, which is a notoriously multi-drug
resistant Gram-negative bacterium. According to the 2019 Antibiotic Resistance Threats Report
published on the Centers for Disease Control and Prevention website, P. aeruginosa was listed as
one of the serious threats for its infections in the U.S.5 P. aeruginosa has an extra outer membrane
3

as opposed to Gram-positive bacteria. The discovery of new antibiotics against especially Gramnegative bacteria is a major challenge, and primarily because of a low hit rate during screening of
compound libraries. In the case of P. aeruginosa, the rate can be up to 1000-fold lower than in the
case of Gram-positive bacteria, and the major reason for such a low hit rate is caused by the low
permeability barrier of this extra outer membrane. 13 In addition, P. aeruginosa has developed
many small-channel porins such that becoming intrinsically resistant towards most antibiotics.

Figure 1-2 Cell wall structure in gram-negative vs. gram-positive bacteria
Among the P. aeruginosa porins, the most important is the Outer membrane Carboxylate
Channel (Occ) family that are dedicated to the uptake of small, water-soluble, carboxylate
containing solutes.6 The Occ family comprise 2 subfamilies, OccD and OccK, which differ in pore
size and structure dynamics. The OccD subfamily has 8 members and the OccK subfamily has 11
members as these structures have been experimentally resolved. The majority of them are available
on Protein Data Bank database and are rendered in Figure 1-3. In general, the OccD porins have a
smaller pore size compared to the ones from OccK subfamily with the exception of some OccD
proteins showing similar sizes as OccK proteins, which suggests that these two subfamilies have
different substrate selectivity. Besides the variation in pore size, it is reported that OccD structures

4

are more dynamic as they can stabilize in either closed or open state, whereas the OccK porins
have a more rigid channel.6-7
As the first member of the Occ family, OccD1 porin has been studied extensively via both
experimental and computational approaches. OccD1 is the least specific channel among the Occ
family, and thus creating a
less restricted access and
allowing

more

efficient

of

relatively

permeation

larger molecules such as
medium-chain fatty acids. In
particular, it shows that
small

structural

modifications
antibiotics

of

known

have

caused

significant impacts on their
permeation through OccD1

Figure 1-3 Occ porins in the order from left to right in cartoon
representation: OccD1, OccD2, OccD3, OccK1, OccK2, OccK3,
OccK4, OccK5, OccK6, OccK7, OccK8, OccK9, OccK10, and
OccK11.

porin.8 Therefore, understanding the porin facilitated translocation behavior is of huge importance
in drug candidate optimization. Interestingly, OccD3 is structurally similar as OccD1, which is a
monomeric protein in β-barrel shape and serves as an uptake channel of arginine and dipeptide in
P. aeruginosa. As recent works showed that OccD3 plays a key role in carbapenem translocation
in P. aeruginosa, it attracts great attention in exploring OccD3 in-depth in the field of antibiotic
resistance study.

5

1.2 Computational Methods
Computational methods possess significant advantages in the study of understanding
biological systems and processes, such as drug molecule-protein residue interactions, as they
provide direct insights at the molecular level. The detailed system initiation, Molecular
Dynamics simulation and umbrella sampling protocol, and python and shell scripting
implemented scripts for analyzing simulation trajectories are distributed and discussed in-depth
in future chapters. Here is a list of advanced computational methods and tools that have been
used throughout my work.

1.2.1 Molecular Dynamics simulation

Figure 1-4 An example of a typical equation used to approximate the atomic forces that govern
molecular movement
Molecular Dynamics (MD) is a computational simulation method that mimics atomic and
molecular movements in real life by solving Newton’s equations of motion. From a knowledge
of the force acting on each atom, it is able to determine the acceleration of each atom in the
system, and therefore obtaining its position and velocity over a period of time and predicting the
future behavior of the system.
MD simulation is able to approximate the interaction energy of each atom within itself
(bonded interaction) and with the surrounding atoms (non-bonded interaction). Figure 1-4
6

demonstrates a typical equation used in calculating total interaction energy by incorporating the
two types, bonded and nonbonded interaction energy.9 Both can be further broken down into
specific terms: bonded interaction includes bond-stretch, angle-bend, and rotate-along-bond terms;
non-bonded interaction comprises of van der Waal’s and electrostatic components.
With the aid of a number of well parameterized force fields, we are able to model and
simulate a wide variety of biomolecules, including amino acids, proteins, lipids, organic
compounds, polymers, and solvents. We conducted MD simulations by using a powerful MD
engine, GROMACS software suite, which has grown out of GROMOS force field and supports
the majority of other well-formulated force fields.

1.2.2 Multiscale modeling
In our research, we have adopted multiscale MD modeling, which combines the all-atom
(AA) and the coarse-grained (CG) resolutions. In atomistic simulations, each atom is calculated to
determine its position and velocity over a period of time. Among many available force fields, we
often use CHARMM force field when we need to perform atomistic equilibrations before moving
forward to coarse-grained simulations. The CHARMM potential energy function is applicable to
a variety of atoms, including but not limited to carbon, oxygen, nitrogen, sulfur, and phosphorous,
and therefore, has been widely used in simulating complex biomolecules, e.g., protein-membrane
systems.14
Coarse grain method groups several atoms into one bead to decrease the amount of
calculation while preserving the molecular properties. Therefore, coarse grained resolution is able
to enlarge the simulation system size and extend simulation timescale comparing to the atomistic
precision. We apply MARTINI approach for coarse graining, which has the advantage of
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transferability of the force field parameters to a wide range of biomolecules and on-demand reverse
mapping to atomistic resolution. 10 MARTINI force field maps four adjoining heavy atoms into
one CG bead, in the meantime it is also flexible to provide three-to-one or five-to-one mapping
scheme if required. The beads are distinguished by their charges, polarities, and structures.

1.2.3 Enhanced sampling
The bottleneck of traditional MD simulation is that there are high-energy barriers
separating two regions of phase or configuration space, which can result in poor sampling as
transitions between them can take a long time to or rarely happen. It is necessary to overcome the
energy barrier to save both simulation time and computational costs. Among many advanced
techniques that have been developed over the past few decades, umbrella sampling has been widely
used to achieve enhanced sampling.11 It works by decreasing the energy barrier between different
structures or conformations so that the transition between these regions is more accessible and
hence, enhancing the sampling.
Umbrella sampling is the first collective variable (or reaction coordinate) based sampling
methods. In umbrella sampling simulations, the collective variable space is divided into many
windows, and time-independent bias potentials are added to each window to obtain the umbrella
potential and estimate the equilibrium probability distribution. Next, the probability distribution
from all windows are calculated iteratively and concatenated using the well-established weighted
histogram analysis method (WHAM). 12 Finally, with the total equilibrium probability distribution
constructed, free energies as a function of the collective variable can be calculated.
Umbrella sampling is the fundamental machinery behind our computational method,
making the MD simulation more powerful and robust.
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2.1 Abstract
Bacterial colonization of biotic and abiotic surfaces and antibiotic resistance are grand

challenges with paramount societal impacts. However, in the face of increasing bacterial resistance
to all known antibiotics, efforts to discover new classes of antibiotics have languished, creating an
urgent need to accelerate the antibiotic discovery pipeline. A major deterrent in the discovering of
new antibiotics is the limited permeability of molecules across the bacterial envelope. Notably, the
Gram-negative bacteria have nutrient specific protein channels (or porins) that restrict the
permeability of non-essential molecules, including antibiotics. Here, we have developed the

ComputationaL Antibiotic Screening Platform (CLASP) for screening of potential drug molecules
through the porins. The CLASP takes advantage of coarse grain (CG) resolution, advanced
sampling techniques, and a parallel computing environment to maximize its performance. The
CLASP yields comprehensive thermodynamic and kinetic output data of a potential drug molecule
within a few hours of wall-clock time. Its output includes the potential of mean force profile,
energy barrier, the rate constant, and contact analysis of the molecule with the pore-lining residues,

and the orientational analysis of the molecule in the porin channel. In our first CLASP application,
we report the transport properties of six carbapenem antibiotics—biapenem, doripenem,
ertapenem, imipenem, meropenem, and panipenem—through OccD3, a major channel for
carbapenem uptake in Pseudomonas aeruginosa. The CLASP is designed to screen small molecule
libraries with a fast turnaround time to yield structure-property relationships to discover antibiotics
with high permeability. The CLASP will be freely distributed to enable accelerated antibiotic drug

discovery.
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2.2 Introduction
Antibiotic resistant bacteria are endangering the efficacy of known antibiotics, which have

saved millions of lives since the middle of the last century.2-5 In the past few decades, antibiotics
have become the most prescribed drugs in human medicine. However, over prescription and
misuse of antibiotics have led to the upsurge in bacterial resistance.6 To make matters worse, the
drug discovery pipeline is at a virtual standstill due to limited profits and regulatory bottlenecks.7
The development of a new antibiotic is a prolonged process requiring years of drug screening, in
vitro testing, clinical trials, and billions of dollars in investment. Therefore, there is an urgent need

to accelerate the screening of drug candidates and develop new antibiotics.8-11
A bottleneck in a drug molecule’s penetration into a bacterial cell is the multilayered
bacterial envelope.12 Both Gram-positive and Gram-negative bacteria have evolved a sophisticated
and complex cell wall that protects them from hostile chemical environments. For Gram-negative
bacteria in particular, their liposaccharide-rich, negatively charged outer membranes with narrow,
water-filled protein channels (or porins) allow selective uptake of nutrients, while preventing the
passage of toxins into the cell.13-14 The chemical nature (lipophilic versus hydrophilic) of the
antibiotic molecule determines whether the permeation occurs via the lipid-mediated or the porin-

mediated pathway.14
A critical step in antibiotic discovery is to identify chemical compounds with high
permeability through Gram-negative bacterial outer membranes. The bacterial outer membrane
porins are passive transporters of water-soluble molecules with a size limit of 600-700 Da.14 , 15-16
Besides mediating uptake of nutrients for survival, porins fortuitously allow the diffusion of
antibiotics across the outer membrane.17-18 For example, β-lactams, including cephalosporins,
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penicillins, and carbapenems, are known to penetrate the outer membrane through the porins.12

These small molecule portals make the bacteria more susceptible to new classes of antibiotics.
Understanding the porin-mediated uptake of small molecules at a molecular-level can spur
the identification of natural compounds or aid in the rational design of new classes of antibiotics.
Screening for penetration experimentally is challenging due to the low-throughput nature of related
procedures. The use of computational approaches can provide molecular insights that are
undetectable via currently available experimental methods.19-25 For example, advanced simulation
approaches, such as metadynamics,21, 26-27 steered molecular dynamics,20, 22 umbrella sampling,2829

and accelerated molecular dynamics simulations30 have been used to simulate translocation

through bacterial porins. However, these and other computational methods do not provide highthroughput thermodynamic and kinetic data of uptake of substrate molecules, precluding the highthroughput screening of libraries of natural compounds as possible antibiotics.
To advance screening of molecular libraries for the identification of potential antibiotics,
in this work, we report the development of the Computational Antibiotic Screening Platform
(CLASP). The CLASP takes advantage of coarse-grained (CG) resolution, advanced sampling
techniques, and a parallel computing environment to maximize performance. The CLASP yields

comprehensive thermodynamic and kinetic data of a solute’s transport through a bacterial outer
membrane porin. Its output includes the potential of mean force profile, energy barrier, rate
constant of the molecule’s transport, contact analysis of the molecule with the pore-lining residues,
and the orientational analysis of the molecule in the porin channel. The CLASP automated
workflow yields result in less than two hours of wall-clock time. The output turnaround times can
be further improved with an increase in computer resources.
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Our first CLASP application focuses on antibiotic uptake by Pseudomonas aeruginosa, a

multi-drug resistant Gram-negative bacterium. Compared to other common Gram-negative
bacterial species, the membrane permeability of P. aeruginosa is about one order of magnitude
lower, primarily due to the presence of substrate-specific porins with sub-nanometer diameters.3132

As a result, the development of new drugs to treat infections caused by P. aeruginosa has been

a major challenge.11 In the 2019 Antibiotic Resistance report, published by the Centers for Disease
Control and Prevention, P. aeruginosa was identified as a serious threat for infections in the United

States.33
Among the P. aeruginosa porins, the most important is the Outer membrane Carboxylate

Channel (Occ) family that are dedicated to the uptake of small, water-soluble, carboxylate
containing solutes. In recent years, several members of the Occ family have been studied, including
OccD1 and OccD3 that facilitate permeation of arginine, dipeptides, and carbapenem antibiotics.3435

As the first member of the Occ family, OccD1 porin has been studied extensively via

experimental 23, 36-39 and computational 20-22 approaches. The closely related OccD1 ortholog,
OccD3 has also been implicated as a channel for carbapenem uptake.34-35, 40 We focused our

investigation on OccD3, which has high structural similarity and higher ion conductance than
OccD1.35 The OccD3 is a β-barrel porin formed by 18 β-strands that are connected by large
extracellular loops and short turns.40 The porin’s lumen is hourglass-shaped, which has a 3.7 Å
diameter bottleneck region (Figure 2-1).
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We investigated six members of the carbapenem family of antibiotics—biapenem,

doripenem, ertapenem, imipenem, meropenem, and panipenem. The carbapenem family is one of
the limited classes of antibiotics that can treat P. aeruginosa infections.41-45 The carbapenems are

Figure 2-1. Molecular structure of OccD3 porin. The (a) side-view and (b) top-view of OccD3 in
cartoon representation (colored blue to red from N-term to C-term) along with the porin channel
(in orange surface representation). The diameter of the channel is marked in circles. The two
horizontal lines show the membrane embedded region of the porin.

effective because they have a lower propensity to enzymatic degradation inside the bacterial cell,
and are therefore, commonly prescribed for the treatment of infections caused by P. aeruginosa.45
Understanding the mechanism of carbapenems’ transport and is imperative to develop new drugs
and reduce the threat of P. aeruginosa.
The results provide the details of the CLASP application and comprehensive analysis of
the translocation profiles of the six carbapenems through OccD3. The free energy profiles and the

energy barriers for carbapenem translocation are consistent with previous reports in the literature.
Besides, we computed the contact frequencies between the carbapenem molecules and each OccD3
protein residue, which identified the key pore-lining residues and revealed the bottleneck
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conformation of the carbapenem molecule during translocation. Additionally, we reverse mapped

the CG structures of carbapenems to atomistic resolution in the bottleneck region to further
illustrate the role of pore-lining residues in the translocation process. Finally, guided by the highfrequency contacts, we mutated two bulky pore-lining residues Y217A and F334A, to create
OccD3m. The effect of mutations in OccD3m provided vital insight into the mechanism of
carbapenem translocation.

2.3 CLASP Workflow
Molecular understanding of the transport of drugs through biological barriers is
fundamental to the future of biomedicine. There is a need to provide robust thermodynamic and
kinetic data for the permeation of drugs that spans nano- to macro-scale. The key is to provide
mechanistic, structural, orientational, conformational, and mutational details of the drug
permeation process that can inform the development of new drugs and accelerate the sluggish drug
discovery pipeline. To cover the spatial and temporal scales involved in the drug transport, we
have adopted a multiscale approach that takes advantage of different resolutions. We use the stateof-the-art umbrella sampling method to compute the potential of mean force (PMF) of permeation
of drugs through bacterial porins.
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Figure 2-2. The CLASP workflow. The systematic representation of CLASP inputs and outputs.
The porin and solute coordinates are the required inputs, which then are processed by the
C_setup.py python script to generate 𝑁 parallel umbrella sampling runs. The post simulation
analysis scripts combine the 𝑁 trajectories to generate the free energy profile, solute-protein
residue contact map, and solute orientational analysis.
Umbrella sampling (US) simulations 46 are often laborious and typically require frequent
user interventions at multiple steps. To streamline US simulations by eliminating the need for
manual interventions, CLASP employs an efficient algorithm for the permeation of sm all
molecules through bacterial porins. To maintain fast turnaround time in the current implementation
of CLASP algorithm, we adopted coarse-grain (CG) resolution. Coarse-grain representation
affords larger system sizes and longer timescale simulations by reducing the slow degree of
freedom essential in all-atom simulations. Mapping the atomistic system to CG allows use of a
time step that is one order of magnitude larger; plus, the CG resolution reduces the number of
particles to be tracked in a simulation by at least one additional order of magnitude. Therefore, CG
resolution is often two orders of magnitude more efficient than atomistic systems. The loss of
atomic resolution in the CG simulations can be recovered by reverse mapping the output to
atomistic representation.
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Among the several CG approaches available, MARTINI force field has been used for a
diverse set of biomolecules, including lipids, proteins, solvents, and ions. 19, 47-54 In our previous
work, we developed MARTINI force field parameters for outer membrane lipids for several
pathogenic and nonpathogenic Gram-negative bacterial species.19, 53-54 In CLASP, we retained the
molecular descriptors of the proteins and substrate (here the carbapenems) at the level of
MARTINI CG that recommends mapping four adjoining nonhydrogen atoms to one CG bead. This
approach, popularly employed in biomolecular simulations, preserves the bonded and nonbonded
interactions of the atomistic system and circumvents oversimplification of the molecular
properties. The MARTINI CG has the advantage of transferability of the force field parameters to
a wide range of biomolecules and on-demand reverse mapping to atomistic resolution. 52 In
addition, we employed the PyCGTOOL,55 which semi-automates the parametrization process for
obtaining CG models for small molecules.
The CLASP implementation is compatible with the GROMACS 5.0 simulation package.56
The program uses a series of python scripts for building the input files, setting up parallel
simulation runs, and performing post-simulation analysis. The workflow enables highlyautomated simulations (Figure 2-2). The CLASP workflow and implementation used are described
as follows.
CLASP input. The CLASP requires two inputs, the three-dimensional structure and
coordinates of the bacterial outer membrane protein and the potential antibiotic or the solute
molecule.
Solute molecule. The MARTINI force field parameters from the literature will be adopted
for small molecules when available. Otherwise, we recommend employing the PyCGTOOL. 55
This python script generates the molecule’s CG model parameters based on its atomistic dynamical
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data. The automated script provides molecular topologies and CG parameters with high chemical
fidelity to the atomistic structure.
Bacterial outer membrane protein. The structure of the OccD3 bacterial protein is obtained
from the Protein Data Bank. Missing residues are built via homology modeling using the
standalone YASARA software 57 or online SWISS-MODEL server.58 Next, the protein is
embedded in a bacterial membrane and thermally equilibrated in the all-atom representation using
standard MD packages or the CHARMM-GUI server.59 The equilibrated protein is then converted
to CG resolution using the MARTINI approach.
CLASP set up and production. In the setup stage, all systems are in the CG
representation. The CG protein is embedded in CG bacterial lipids using Bacterial Outermembrane

Figure 2-3. The CLASP simulation setup. The membrane embedded porin channel oriented
parallel to the z-axis is divided into 𝑁 equidistant umbrella sampling windows. The probe
molecule is inserted into each 𝑊𝑖 window.
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Builder script (BOB.py),53-54 an in-house modified insane.py script 60 that includes CG parameters
for bacterial outer membranes. The protein is embedded in an asymmetric patch of the outer
membrane lipids and is solvated with standard MARTINI water. The system’s energy is then
minimized, followed by equilibration in the isothermal-isochoric (NVT) and isothermal-isobaric
(NPT) conditions. The output of the NPT run is the starting structure for CLASP.
In the next step, bacterial membrane is generated in the xy-plane and the porin is embedded
in the membrane such that the porin channel is along the z-axis. The molecule’s permeation
coordinate (𝑠) is parallel to the z-axis, and the length of the porin channel from the extracellular
region to the periplasmic region along 𝑠 is denoted by 𝐿𝑠 (Figure 2-3). The free energy profile
along 𝑠 is generated by dividing 𝐿𝑠 into 𝑁 umbrella sampling windows (𝑊𝑖 ) with uniform spacing
of 𝐿𝑠 ⁄𝑁 nm. The solute molecule is inserted in each 𝑊𝑖 window, where the insertion coordinates
are computed relative to the center-of-mass (COM) of the porin. Given, the hourglass shape of the
porin, the COM lies in the middle of the porin channel. The location of the COM is considered
𝑊𝑁⁄2 , with an equal number of windows on either side.
Next, the CLASP script generates 𝑁 separate folders, each with a unique location of the
substrate molecule defined within 𝑊𝑖 , totaling the length 𝐿𝑠 along 𝑠. Each folder is set up to
execute energy minimization and US simulations independently. The 𝑁 jobs run concurrently on
separate computer cluster nodes for maximum efficiency and shortest completion time.
CLASP analysis. The CLASP outputs are four primary outputs from a CLASP run:
Free energy profile. The potential of mean force (PMF) profile of the solute molecule’s
transport from the extracellular to the periplasmic region is computed along the one-dimensional
translocation coordinate (𝑠) .The C_PMF.py script combines the trajectories from the 𝑁 folders to
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generate the PMF profile of the solute molecule. The PMF average profile with standard deviations
were obtained using a GROMACS built-in utility. The detailed usage of the script is provided in
the Supporting Information.
Permeation barrier. the barrier height (BH) for the solute’s permeation is calculated by
taking the difference between the maximum and the minimum energy points along 𝑠. Using the
transition state theory as a first-order approximation of the solute translocation, we defined rate
constant as 𝑘 = ( 𝑘𝐵 𝑇⁄ℎ) 𝑒𝑥𝑝(−𝐵𝐻 ⁄𝑅𝑇), where 𝑘B is the Boltzmann constant, R is the gas constant,
and T is the temperature.
Orientational analysis. The orientation of the solute molecule is quantified by defining the
interatomic vector connecting head bead to the tail bead of the solute molecule, 𝑟⃗ = ⃗⃗⃗⃗
𝑟𝑇 − 𝑟⃗⃗⃗⃗⃗
𝐻 .
𝑟⃗

Based on the angle 𝜃 that the unit vector 𝑑̂ = |𝑟| makes with the z-axis, we used 𝑑𝑧 = |𝑑 | cos 𝜃 to
determine in the orientation of the molecule, where 𝑑𝑧 ∈ [−1, 1]. If 𝑑𝑧 = 1, the molecule is
orientated headfirst towards the translocation direction, and 𝑑𝑧 = −1 for tail first. If 𝑑𝑧 = 0, then
the molecule lies in the xy-plane, perpendicular to the z-axis.
Contact analysis. The interaction of the solute molecule with the protein residues is
performed for all 𝑁 windows. A contact is defined to have formed between the solute and protein
residue if the distance between any of their beads is within a 1.2 nm cut off. A contact receives a
value of either 1 when formed or 0 when the contact is broken. The cumulative number of contacts
made by the solute with each protein residue in 𝑁 windows is calculated. The residues are sorted
from smallest to largest based on the total number of residue-solute contacts to identify the highest
contacting residues (99th percentile).
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Reverse mapping. The on-demand CG to atomistic reverse mapping is available to
determine the atomistic level interactions of the solute molecule with the pore-lining residues.52

2.4 Methods
Carbapenem coarse graining. The MARTINI CG parameters for the carbapenem
molecules were developed based on many-to-one mapping. PyCGTOOL was used to generate the
CG coordinates and topologies for all solute molecules. Benchmarking of the CG parameters
against the atomistic models was performed using the PyCGTOOL. The CG mapping of the
carbapenem molecules are shown in Figure 2-4. The force field parameters of all six carbapenems
are provided in Tables 2-2 – 2-7.
Porin structure. The x-ray crystallographic structure of OccD3 was obtained from the
Protein Data Bank (PDB ID: 3syb), and the missing residues were built using the SWISS-MODEL

server. The structure was then optimized in atomistic representation using the CHARMM36 force
field.61 The NVT and NPT simulations were performed for 200 ns each at T = 320 K. The point
mutations in the OccD3 structure were generated using the CHARMM-GUI webserver.59 The
mutated structures were then optimized using the same approach outlined above for the OccD3.
Porin-membrane system. The CG mapping of the OccD3 was performed using
martinize.py script. The MARTINIv2.1 force field parameters50 were used along with the
ELNeDyn network49 constraint to maintain the porin’s secondary structure. The porin was inserted

in a 10×10 nm2 patch of the P. aeruginosa membrane using the BOB.py script. The membrane’s
outer leaflet consisted of P. aeruginosa’s lipid A and

1,2-dipalmitoyl-sn-glycero-3-

phosphoethanolamine (DPPE) in 9:1 ratio and pure DPPE in the lower leaflet. The membrane was
placed in a 10×10×12 nm3 simulation box and solvated with MARTINI water (9:1 of W:WF) and
150 mM CaCl2. The molecular composition of the simulation box is provided in Table 2-8.
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Figure 2-4. Atomistic to CG mapping for (a) biapenem, (b) doripenem, (c) ertapenem, (d)
imipenem, (e) meropenem, and (f) panipenem showing the MARTINI bead type assignments
along with positive and negative charges. The red bead, which is part of the β-lactam ring, denotes
the head and the yellow bead, the farthest bead from the β-lactam ring, denotes the tail.
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CG MD Simulation. The GROMACS 5.1.2 package56 was used for CG MD simulations.

The system was energy minimized using the steepest-decent algorithm until the maximum force
on any bead was below the tolerance parameter of 10 kJmol−1nm−1. This was followed by NVT
and NPT equilibration for 0.02 µs and 2 µs, respectively. A 20 fs time step was used for the
equilibration and production runs. The temperature was set to 320 K for all systems using the vrescale thermostat with τt = 1 ps. A semi-isotropic pressure coupling of 1 bar was maintained using
Berendsen barostat 62 with τp = 4 ps. Both the nonbonded van der Waals and electrostatics

interaction cut offs were set to 1.2 nm. Periodic boundary conditions were applied in all three
dimensions.
CLASP production. A total of 𝑁 independent simulations were perfomed concurrently on
separate computer nodes (Table 2-9). Within each window the simulations were performed in two
steps. The first US run was performed for 0.2 µs using a 20 fs time step. The OccD3 protein and
the solute molecule were position-restrained with a 1000 kJmol−1nm−2 force constant. In the second
step, the US simulation was run for 1 µs with a 20 fs time step. The position restraint of the drug
molecule was removed in this step with all other parameters maintained. The harmonic potential

with a force constant of 3000 kJmol−1nm−2 was used. A cut off of 1.1 nm was used for both the
long-range electrostatic and the nonbonded van der Waals interactions. The potential-shift-Verlet
algorithm was applied to shift the van der Waals interactions beyond the cut off. The Coulombic
interactions were calculated using the reaction-field algorithm. The temperature was maintained
at 300 K using the v-rescale thermostat with τt = 1.0 ps.
Analysis. Post simulation analyses were performed using CLASP python scripts. We
computed the histograms of the US window along the translocation path (Figures S1-S6). The
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CAVER plugin63 available in PyMOL was used for OccD3 channel analysis. Molecular

visualization and graphics were generated using VMD,64 PyMOL,65 and YASARA.57

2.5 Results and Discussion
The CLASP simulations were employed to characterize and compare the permeabilities of
six carbapenems— biapenem, doripenem, ertapenem, imipenem, meropenem, and panipenem—
through the wildtype OccD3 porin. The role of pore-lining residues involved in carbapenem
translocation was further evaluated by site-directed mutagenesis of Y217 and F334 residues to
alanine in the double mutant OccD3 (OccD3m) porin. The results provided detailed insight into
the uptake mechanism and demonstrated the robustness of the CLASP method in capturing the

effects of point mutations.

2.5.1 Carbapenem uptake through OccD3 channel with characteristic PMF
The PMF profile of each carbapenem molecule’s transport from the extracellular to the

periplasmic region of the OccD3 porin was studied in the 𝑠 ∈ [0, 11] nm range. For clarity, in this
discussion, the 𝑠 coordinate is subdivided into three sections—the extracellular region with the
porin vestibule, 𝑠 ∈ [0 − 4.2] nm; the porin constriction region, 𝑠 ∈ [4.2 − 7.4] nm; and the
periplasmic region, 𝑠 ∈ [7.4 − 11.0] nm.
In the extracellular region, the carbapenem molecule interacts freely with the porin loops
and shows an energy minimum at the pore vestibule 𝑠 = 4.2 nm. Each carbapenem is different in
molecular size (Table 2-1) and functional groups attached to the β-lactam ring (Tables 2-2 – 2-7),
so free energy variations among the carbapenems are expected; however, stabilization before

penetrating the porin channel is observed in all six cases (Figure 2-5). The free energy profile of
all six carbapenems except doripenem show approximately 10 kcal mol−1 stabilization at 𝑠 = 4.5
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nm. Beyond the extracellular vestibule, the free energy increases for all carbapenems until they

reach the bottleneck.
Table 2-1 Molecular weight (MW), barrier height (BH), and rate constant (k) of six carbapenems
through OccD3 and OccD3m.
OccD3
Antibiotic

MW
(Da)

Biapenem

350.4

BH
(kcal
mol−1)
27±2.5

Doripenem

420.5

Ertapenem

k
(s−1)

OccD3m

1.4×10-7

BH
(kcal
mol−1)
15±2.1

k
(s−1)
7.6×101

20±3.2

1.7×10-2

16±2.2

1.4×101

474.5

31±2.8

6.0×10-12

10±2.5

2.1×10-5

Imipenem

299.4

22±2.1

1.1×10-4

16±1.6

1.4×101

Meropenem

383.5

21±1.8

3.3×10-3

14±1.6

4.1×102

Panipenem

339.4

26±2.3

7.5×10-7

12±2.2

1.2×104

A comparison of the free energy barrier for translocation through the OccD3 pore shows a
range between 20-31 kcal mol−1 (Table 2-1). In OccD1, the translocation barriers for positively

charged amino acid substrates vary between 5-10 kcal mol−1.21 Energy barriers are three to four
times higher for permeation through OccD3 than OccD1, which is expected because OccD3 has
more constrained channel and contains a unique N-terminal extension loop.34
We observe a weak correlation between the magnitude of the energy barrier and the
molecular size of the carbapenem molecule. Ertapenem is the largest carbapenem and has the
highest BH = 31±2.8 kcal mol−1. Imipenem, which is the smallest carbapenem, has one of the
smallest BH = 22±2.1 kcal mol−1. The similarly sized, biapenem and panipenem, have energy
barriers of BH = 27±2.5 and 26±2.3 kcal mol−1, respectively. Meanwhile, doripenem, which is the

second largest in terms of MW, has the lowest BH = 20±3.2 kcal mol−1. The results indicate that
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the molecular size of the carbapenems is not the only criteria that determines the magnitude of the

energy barrier. In a previous study, Soundararajan et al., reported that meropenem interacts more
strongly with the OccD3 porin than imipenem using ion conductance measurements35; however
Table 1 shows that both molecules have similar barrier heights. To investigate the differences in
energy barriers, we evaluated the interactions of carbapenem molecule throughout the porin
channel with emphasis on the bottleneck region. A detailed discussion of the carbapenem
conformation at the bottleneck region of the pore is provided in Section 2.5.3.
The rate constant (s −1) of the six carbapenems are shown in Table 2-1. Rate constants are
calculated by assuming a first order transition state theory and are directly related to energy
barriers. They are used to distinguish the relative rate and preference of carbapenems permeating
through OccD3. Between ertapenem (BH = 31±2.8 kcal mol−1) and doripenem (BH = 20±3.2 kcal
mol−1), which has the largest and smallest energy barriers, the rate constants are different by
multiple orders of magnitudes. We further compare the rate constants of mutations, which will be
discussed in Section 2.5.4.
It is apparent from the thermodynamic that besides the molecular size of the translocating
molecule, the orientation of the molecule in pore’s constriction region can also be crucial. For this

purpose, we evaluated the orientation of the carbapenem molecule along 𝑠 ∈ [0 − 11.0] nm. The
orientation profiles of the six carbapenems were somewhat similar in the extracellular and
periplasmic regions. In all cases, the carbapenem adopted a wide range of orientations, indicated
by the large deviation in the average 𝑑𝑧 values in both the extracellular region 𝑠 ∈ [0 − 4.2] nm
and the periplasmic region, 𝑠 ∈ [7.4 − 11.0] nm (Figure 2-6). However, in the constriction zone,
the solute molecule is restrained by the channel walls, which was manifest in small deviations in
the 𝑑𝑧 values.
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Figure 2-5. The PMF profiles of carbapenems through OccD3 and OccD3m. The comparison of
(a) biapenem, (b) doripenem, (c) ertapenem, (d) imipenem, (e) meropenem, and (f) panipenem
translocation through OccD3 (black line) and OccD3m (red line). The error bars calculated using
the bootstrap analysis are marked in gray. The barrier heights (dashed lines) are marked in each
panel. The translocation coordinate (s) is subdivided into outer membrane region (green),
constriction zone (white) and periplasmic region (blue).
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Figure 2-6. Orientational analysis of carbapenems along the translocation coordinate in OccD3.
The variation in dz for (a) biapenem, (b) doripenem, (c) ertapenem, (d) imipenem, (e)
meropenem, and (f) panipenem as a function of s. The mean dz values are denoted by the yellow
dots, and the standard deviations are shown by the black bars. The 𝑠 coordinate is subdivided
into outer membrane region (green), constriction region (white) and periplasmic region (blue).
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2.5.2 Carbapenems make highest contact with bulky Y217 and F334 OccD3
residues
Using the molecular interaction data of the carbapenem molecules with the OccD3
residues, we generated the contact maps. The contact map provides a percentile-based overview
of contacts the molecule makes with each of the 452 OccD3 residues (Figure 2-7). All carbapenems
have the same set of highest contact residues, namely Y169, Y217, Y326, H328, and F334 (Figures
S7-S12). In fact, comparing the full contact map between all carbapenems, the most contacted
residues (>80th percentile) are consistent. This reflects the dominant role of these residues in
kinetics of carbapenem uptake. Besides, the importance of the charged D342 and R449 residues
was shown by Soundarajan et al. in the ion-conductance experiments involving molecular uptake
of imipenem and meropenem via OccD3 porin; the authors demonstrated that both mutations
D342H (charge reversal) and R449A (charge neutralization) disturbed the translocation of
imipenem and meropenem molecules. 35
Notably, in OccD1 carbapenem transporter, residues Y176, Y282, D307, Y305 and D295
have been reported as the most probable pore-lining residues; 21 the sequence alignment between
OccD3 and OccD1 (Table 2-10) shows that Y176 and Y282 in OccD1 match Y217 and Y326 (99 th
percentile residues) in OccD3, and D307, Y305 and D295 in OccD1 match D342, L340 and S331
(90th percentile residues) in OccD3. These results confirm that both OccD3 and OccD1 are
carbapenem transporters.
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Figure 2-7 Interaction of meropenem with OccD3 porin channel. (a) Meropenem-OccD3 contact
map, and (b) structure of the OccD3 (cartoon representation, gray) along with key pore-lining
residues (stick model) that line the channel (orange, surface representation).
All six carbapenems make contacts with a series of charged arginine and lysine residues

(Figures S7-S12), which constitutes the basic ladder. These observed interactions with the charged
residues are consistent with the earlier reports involving uptake of substrates via OccD3 and
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OccD1 porins. The presence of the basic ladder is considered crucial in providing the Coulombic

interactions for the substrate to translocate through the porin channel.
Previous experimental and computational studies have focused on evaluating the role of
charged residues in OccD3 and OccD1 channels.35, 40 However, the steric effect of bulky porelining residues in OccD3 channel have not been investigated. Using CLASP, we explore the effect
of two bulky residues—F334 and Y217—that make the first and second highest frequency contacts
in all six carbapenems. As shown in Figure 2-7b, Y217 lies at the tip of the constriction zone on
the extracellular side. The F334 is the most important hydrophobic residue in OccD3 that contacts
all six carbapenems in their highest energy structures. We hypothesized that a double mutation of

bulky residues Y217 and F334 to alanine would increase channel diameter and lower the energy
barrier to carbapenem permeation. We also expect that these mutations will not cause the
carbapenem to adopt a new pathway in the channel.
Remarkably, in OccD3m, the top residue contacts (99th percentile) for all six carbapenems
are identical as well (Y169, N172, R173, Y326, S331), and the top 90th percentile contacts are
fairly consistent (Figure S7-S12). Contact maps of OccD3 and OccD3m have similar mostcontacted residues regions, which confirms the presence of a single pathway through the porin.

The double mutation shows that the two bulky residues play a significant role in creating the
bottleneck in the porin pathway. The discussion on the mechanism of carbapenem translocation
through OccD3m is provided in Section 2.5.4.
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2.5.3 Conformation of the carbapenem at the bottleneck in the OccD3
channel influence the energy barrier to translocation
The orientational and contact map analysis of the carbapenem molecules in the OccD3

channel indicates the strong interplay between the carbapenem structure and the pore-lining
residues in determining the energy barrier to the translocation. The chemical groups attached to
the β-lactam ring in different carbapenems impact the conformational flexibility of the molecule,
which can be an important factor at the pore’s bottleneck region.
For this purpose, we reverse mapped the carbapenem molecule and porin from CG to
atomistic resolution and evaluated their molecular interactions in the bottleneck conformation. In
biapenem, the molecule is oriented tail first with 𝑑𝑧 = −1.0 at 𝑠 = 5.4 nm, and then fliped to 𝑑𝑧 =
0.9 after the bottleneck (Figure S13). At 𝑠 = 5.4 nm, biapenem showed interactions with Y169,

N172, F334, and M339. These interactions were also observed as high frequency contacts (90th
percentile) in the contact map (Figure S7).
Doripenem was in a folded-state with the β-lactam ring pointing towards the periplasm at
𝑠 = 6.1 nm, which corresponds to the bottleneck region (Figure S14). The contacting pore
residues are N163, P165, Y169, and F334; the former three residues can be found from the high
(90th percentile) contacts and F334 belongs to the group of the highest (99th percentile) frequency
contacts (Figure S8).
The ertapenem molecule is fully extended and is aligned with its tail pointing towards the
periplasm (Figure S15). This orientation is maintained for much of the constriction zone for

𝑠 from 4.5 to 6.5 nm beyond which the molecule eases out of the fixed orientation as it diffuses
out to the periplasmic region. As expected, ertapenem is the largest carbpenem we studied (MW
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474.5 Da), and it does experience the highest energy barrier to the translocation. At 𝑠 = 5.7 nm,

the molecule makes multiple contacts with pore-lining residues. These residues include the bulky
Y169 and F334 that constrict the channel, and polar residues N172, S331, and S338 that provide
stabilization.

Imipenem is the smallest of the six carbapenems and is able to translocate through the pore
in an oblique orientation with 𝑑𝑧 = −0.5 (Figure S16). The primary residue contacts at the highest
point in energy profile are I170, S331, and F334, which unlike the other five carbapenems, does
not include Y169. As a result of the small size of imipenem, fewer bulky contacts are experienced
and therefore, reducing the energy barrier to translocation.
Meropenem has an orientational profile similar to imipenem. The contacting residues at

𝑠 = 5.6 nm include the bulky Y169 and F334 residues, nonpolar I170, polar S168, and charged
D171 (Figure S17). The orientation of the molecule causes it be in contact with residues that have
high variability in their side chain size and polarity. Despite the slightly bigger size of meropenem
from the six carbapenems, it has a quite small energy barrier.
Panipenem is a relatively small carbapenem (MW 339 Da) and it underwent only a few
orientational flips as it navigated the constriction zone. At the highest energy point, the molecule
adopted an L-shaped geometry with 𝑑𝑧 = 1.0 (Figure S18). The contacting residues include four
bulky groups Y169, Y217, Y326, F334, and polar D171.
This work demonstrates that the differences in the carbapenem orientation, contacting
residues, and location of the bottleneck along the translocation path are the contributing factors to

the varibality in the energy barrier and the translocation rates. This detailed analysis is possible
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due to the robustness of the CLASP alogirthm that can provide the on-demand reverse mapped

structure of the simualtion system at atomistic-level precision.

2.5.4 Carbapenems have lower permeation barrier through OccD3m
The free energy profile of each carbapenem through OccD3m (Figure 5, red lines) show
lower barriers than through OccD3. The barrier heights and rate constants results of carbapenems
via OccD3m and OccD3 channels are provided in Table 2-1.

Figure 2-8. Comparison of reserve-mapped atomistic structure and orientation of ertapenem
in the bottleneck region, 𝑠 = 5.8 nm of (a) OccD3 and (b) OccD3m channel. The contacts
the molecules make with the pore-lining residues in their highest energy conformation. The
porin is shown in ribbon representation (blue to red from N-term to C-term) and ertapenem
is shown as sticks (C cyan; O red; H white; S gold; and N blue). The pore-lining residues are
shown in stick representation Y217 and A217 (C green), and F334 and A334 (C orange); the
other atoms have same color scheme as in ertapenem.
Interestingly, the largest change in barrier height for translocation occurred in ertapenem
(ΔBH = 21 kcal mol−1), the largest carbapenem in the group studied. In contrast, one of the smallest
changes in all six carbapenems occurred with imipenem (ΔBH = 6 kcal mol−1), the smallest

carbapenem in the group. A close up view of ertapenem's molecular interactions with OccD3 and
OccD3m at 𝑠 = 5.8 nm, the highest energy point, reveals the reason for the change in free energy
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(Figure 2-8). The minimum in OccD3m is possible because the large ertapenem molecule is

stabilized by the added volume created by concurrent Y217A and F334A mutations; none of the
other five carbapenems were large enough to experience this dual volume increase.
Furthermore, the orientational profile comparison of the six carbapenems through OccD3
and OccD3m supports our hypothesis that Y217 and F334 influence the translocation behavior.
The carbapenem orientational analysis for translocation through the OccD3m pore shows a higher
number of flips in the constriction region (Figure S19). The widening of the pore provides small
pockets for the molecules to orient in different conformations as they navigate the translocation
coordinate.

2.6 Conclusions
Here we report the developement of a new computational screening platform called

CLASP that is designed to accelerate the antibiotic discovery process. This computational platform
provides an automated screening of small molecules by quantifying their permeabilities through
the bacterial outer membrane porins. The CLASP outputs comprehensive thermodynamic data,
which includes, potential of mean force profile, energy barrier, translocation rate constant, contact
analysis of the molecule with the pore-lining residues, orientation analysis of the molecule within
the porin, and the overall mechanism of the antibiotic uptake. Additionally, the fast turnaround

times will enable the establishment of structure-property relationships among molecular species
that have high bacterial membrane permeability.
In this first application of CLASP, we demonstrate the permeability profile of six, wellestablished antibiotics from the carbapenem family through P. aeruginosa‘s OccD3 channel. The
proof-of-concept study was undertaken to use the known literature and illustrate the permeability
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profiles for biapenem, doripenem, ertapenem, imipenem, meropenem, and panipenem. The results

show excellent agreement with the barrier heights, the key residues, and the translocation rate
constants of the drug molecules. We were able to identify critical pore-lining residues in the OccD3
channel that provide steric gating. Mutation of these residues to less bulky groups enhanced the
predicted rates. Moreover, the wall-clock time to simulate one antibiotic molecule was less than
two hours based on the current computational resource.
In conclusion, our goal was to advance strategies that will facilitate the identification of
new antibiotics. This work has enabled comprehensive characterization of antibiotic uptake
through bacterial envelope. In the future, we plan to employ CLASP to screen large natural

compound libraries to identify the new potential antibiotics.
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2.8 Supporting Information
The contents include description of the CLASP python scripts, coarse grain-mapping of
the six antibiotics, simulation setup details, contact maps, and reversed mapped orientational
analysis of the antibiotics in OccD3 channel, and orientational analysis of carbapenems along t he
translocation coordinate in OccD3m.

2.8.1 Description of the CLASP python scripts
The CLASP program is designed to facilitate high-throughput screening of small molecule
solutes that have the potential of being antibiotic drugs. The solute molecules can include
compounds available in natural compound libraries and other synthetic compounds that can be
transported into the bacterial periplasm through the porin channels. The salient features of CLASP
program are:
− automates the tedious umbrella sampling simulation set up. The user provides the desired
number of umbrella sampling windows (𝑁) and length (𝐿𝑠 ) of the translocation
coordinate, which roughly corresponds to the length of the porin channel.
− minimizes the amount of effort to prepare the simulation set up. Only structure of the solute
molecule and the porin need to be provided.
− streamlines the input and output workflow. All programs are executed by simple command
line. No additional programming is required. CLASP offers user-friendly organization of
output as separate labeled folders of the simulation runs will be generated and well labeled.
All necessary topologies and parameter files needed for the simulation are added
automatically to the simulation folders.
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− accelerates the simulations of transport mechanisms. CLASP reaches 3 µs/day based on
the current resources.
− analyses simulation results as CLASP provides a variety of outputs, including the potential
of mean force, transport barriers, molecular orientations during translocation, and contact
map of molecule-protein residues, etc.
The description of the input and output scripts are as follows:
C_setup.py generates umbrella sampling configurations.
The C_setup.py script takes the membrane-embedded, solvated, and equilibrated porin
structure as input along with two user defined parameters:
(a) length, 𝐿𝑠 , of the translocation coordinate (𝑠) , which roughly corresponds to one and a
half times of the length of the porin channel; default value = 11 nm
(b) 𝑁, the number of umbrella sampling (US) windows, default value is 100. The user can
change 𝑁 to check for convergence.
The C_setup.py script then prepares 𝑁 independent US windows with spacing of 𝐿𝑠 ⁄𝑁
nm. In each window, 𝑊𝑖 , the script inserts the probe substrate molecule using gmx insertmolecules utility available in GROMACS. The coordinates for the insertion of substrate
molecule in each window is computed relative to the center-of-mass (COM) of the porin.
Given the hourglass shape of the porin, the COM lies in the middle of the porin channel.
The location of the COM is considered 𝑊𝑁⁄2 , with equal number of windows on either
side.
Next, the C_setup.py script generates 𝑁 separate folders, each with unique location of the
substrate molecule defined within 𝑊𝑖 , totaling the length 𝐿𝑠 along the translocation
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coordinate. Each folder is set up to execute energy minimization and umbrella sampling
simulations independently. The 𝑁 jobs run concurrently on separate nodes for maximum
efficiency and shortest run completion times.
C_PMF.py generates potential of mean force profile along the transport coordinate.
The C_PMF.py script combines the 𝑁 umbrella sampling simulation run-input files (.tpr
files) into one file (tpr.dat) and combines the 𝑁 umbrella sampling simulation output files
(*f.xvg files) into one file (fxvg.dat). The two combined files are used as the two input files
with gmx wham, a GROMACS built-in utility, along with the error analysis (bootstrap) to
generate the potential of mean force plot. Bootstrap analysis is the error analysis available
from the gmx wham program to estimate statistical uncertainty. In this study, 200
bootstraps were used as recommended from the GROMACS manual to calculate the
standard deviations.
C_Dz.py generates the orientational analysis of the molecule along the transport coordinate.
The C_Dz.py script reads the x-, y- and z-axis coordinates of the solute molecule during
the transport process using gmx distance, a built-in Gromacs utility with one of its options,
-oxyz. Then the script extracts the z-component data and calculates the average and the
standard deviation. Finally, the z component is converted to the molecular orientation,
which is explained in the main paper.
C_contact.py generates the contact map of the molecule with the protein residues along the
transport coordinate.

41

The C_contact.py script calculates the cumulative number of contacts made by the solute
molecule with each protein residue throughout the whole trajectory as described in the
main paper. Then the script plots the contact map based on the numbers.
In summary, the CLASP is designed to work with GROMACS 5.0 package and later. The
CLASP is developed to support outer membrane porins of all bacterial species with porin, provided
the porin structure is available. The porins can be embedded in lipopolysaccharide-rich,
asymmetric lipid membrane using the BOB.py script, which currently has MARTINI coarsegrained parameters of ten Gram-negative bacterial lipids. The CLASP can be easily extended to
include new bacterial species once their lipid parameters become available.
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2.8.2 Supporting Tables

Figure 2-9 Biapenem
Table 2-2 CG mapping and parameters for Biapenem
Bond
1-2
1-3
2-3
2-4
3-4
3-5
5-6

Kbond (kJ mol-1 nm-2)
5000
5000
5000
5000
5000
5000
5000

R(nm)
0.297
0.420
0.332
0.295
0.334
0.464
0.252

Angle
1-2-4
1-3-4
1-3-5
2-3-5
4-3-5
3-5-6

θ (deg)
145
96
148
112
67
152

Kangle (kJ mol-1)
50
50
50
50
50
50
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Figure 2-10 Doripenem
Table 2-3 CG mapping and parameters for Doripenem
Bond
1-2
1-3
2-3
2-4
3-4
3-5
5-6
6-7

Kbond (kJ mol-1 nm-2)
5000
5000
5000
5000
5000
5000
5000
5000

R(nm)
0.292
0.422
0.329
0.300
0.334
0.371
0.247
0.324

Angle
1-2-4
1-3-4
1-3-5
2-3-5
4-3-5
3-5-6
5-6-7

θ (deg)
146
96
150
129
84
137
134

Kangle (kJ mol-1)
50
50
50
50
50
50
50
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Figure 2-11 Ertapenem
Table 2-4 CG mapping and parameters for Ertapenem
Bond
1-2
1-3
2-3
2-4
3-4
4-5
5-6
6-7
7-8

Kbond (kJ mol-1 nm-2)
5000
5000
5000
5000
5000
5000
5000
5000
Constrained

R(nm)
0.268
0.566
0.304
0.325
0.339
0.362
0.279
0.385
0.312

Angle
1-2-3
1-3-4
2-4-5
3-4-5
4-5-6
5-6-7
6-7-8

θ (deg)
104
56
128
87
119
134
103

Kangle (kJ mol-1)
50
50
50
50
50
50
50
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Figure 2-12 Imipenem
Table 2-5 CG mapping and parameters for Imipenem
Bond
1-2
1-3
2-3
2-4
3-4
3-5

Kbond (kJ mol-1 nm-2)
5000
5000
5000
5000
5000
5000

R(nm)
0.293
0.434
0.316
0.301
0.305
0.494

Angle
1-2-4
1-3-4
1-3-5
2-3-5
4-3-5

θ (deg)
149
99
134
122
85

Kangle (kJ mol-1)
50
50
50
50
50
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Figure 2-13 Meropenem
Table 2-6 CG mapping and parameters for Meropenem
Bond
1-2
1-3
2-3
2-4
3-4
3-5
5-6

Kbond (kJ mol-1 nm-2)
5000
5000
5000
5000
5000
5000
5000

R(nm)
0.297
0.410
0.329
0.303
0.334
0.494
0.343

Angle
1-2-4
1-3-4
2-4-5
3-4-5
4-5-6

θ (deg)
143
99
114
55
106

Kangle (kJ mol-1)
50
50
50
50
50
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Figure 2-14 Panipenem
Table 2-7 CG mapping and parameters for Panipenem
Bond
1-2
1-3
2-3
2-4
3-4
3-5
5-6

Kbond (kJ mol-1 nm-2)
5000
5000
5000
5000
5000
5000
5000

R(nm)
0.293
0.434
0.316
0.301
0.334
0.403
0.311

Angle
1-2-4
1-3-4
1-3-5
2-3-5
4-3-5
3-5-6

θ (deg)
146
99
138
143
103
142

Kangle (kJ mol-1)
50
50
50
50
50
50
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Table 2-8 Composition of the system with embedded OccD3 protein
Antibiotic
Biapenem
Doripenem
Ertapenem
Imipenem
Meropenem
Panipenem

LPS
54
54
54
54
54
54

outer
DPPE
6
6
6
6
6
6

inner
DPPE
141
141
141
141
141
141

W
W
5625
5625
5625
5625
5625
5625
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WF
625
625
625
625
625
625

Ions
Ca
Na+
58
1
58
1
58
1
58
1
58
1
58
1
2+

Table 2-9 Values of Umbrella sampling windows (N) used for the six carbapenem simulations
Antibiotic
Biapenem
Doripenem
Ertapenem
Imipenem
Meropenem
Panipenem

N value
400
400
400
400
400
400

An optimal number for N depends on both the size of the drug molecule, and the length
of the reaction coordinate. A poor sampling will appear as a gap area in the histogram. When N
is inadequate, there will be gaps in the histograms. The user needs to adjust the value of N to
achieve better sampling along the entire reaction coordinate. In this study, 100, 200, and 400 for
N were tested and the data was converged at 200. In the interest of maximum statistical data, the
results for N = 400 are provided.
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The black dots denote identity. The key pore-lining residues identified in OccD3 are
marked in blue outlines.
Table 2-10 Pairwise sequence alignment of OccD3 and OccD1

51

2.8.3 Supporting Figures

Figure S 1 Histogram of Biapenem with OccD3
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Figure S 2 Histogram of Doripenem with OccD3
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Figure S 3 Histogram of Ertapenem with OccD3
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Figure S 4 Histogram of Imipenem with OccD3
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Figure S 5 Histogram of Meropenem with OccD3
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Figure S 6 Histogram of Panipenem with OccD3
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Figure S 7 Contact map of Biapenem with (a) OccD3 and (b) OccD3m
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Figure S 8 Contact map of Doripenem with (a) OccD3 and (b) OccD3m
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Figure S 9 Contact map of Ertapenem with (a) OccD3 and (b) OccD3m
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Figure S 10 Contact map of Imipenem with (a) OccD3 and (b) OccD3m
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Figure S 11 Contact map of Meropenem with (a) OccD3 and (b) OccD3m
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Figure S 12 Contact map of Panipenem with (a) OccD3 and (b) OccD3m
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Figure S 13Reserve mapped atomistic structure and orientation of Biapenem in the (a) OccD3
channel and the (b) contacts the molecule makes with the pore-lining residues in the highest energy
conformation at s=5.4 nm.
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Figure S 14 Reserve mapped atomistic structure and orientation of Doripenem in the (a) OccD3
channel and the (b) contacts the molecule makes with the pore-lining residues in the highest energy
conformation at s=6.1 nm.
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Figure S 15 Reserve mapped atomistic structure and orientation of Ertapenem in the (a) OccD3
channel and the (b) contacts the molecule makes with the pore-lining residues in the highest energy
conformation at s=5.7 nm.
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Figure S 16 Reserve mapped atomistic structure and orientation of Imipenem in the (a) OccD3
channel and the (b) contacts the molecule makes with the pore-lining residues in the highest energy
conformation at s=5.9 nm.
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Figure S 17 Reserve mapped atomistic structure and orientation of Meropenem in the (a) OccD3
channel and the (b) contacts the molecule makes with the pore-lining residues in the highest energy
conformation at s=5.6 nm.
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Figure S 18 Reserve mapped atomistic structure and orientation of Panipenem in the (a) OccD3
channel and the (b) contacts the molecule makes with the pore-lining residues in the highest energy
conformation at s=6.0 nm.
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Figure S 19 Orientational analysis of carbapenems along the translocation coordinate in OccD3m.
The variation in d_z for (a) biapenem, (b) doripenem, (c) ertapenem, (d) imipenem, (e)
meropenem, and (f) panipenem as a function of s. The mean d_z valued are denoted
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CHAPTER 3.
FINGERPRINTING PLASMA MEMBRANE
LIPIDOME OF HUMAN RED BLOOD CELLS USING
COMPUTATIONAL MODELING TECHNIQUES
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3.1 Abstract
Although asymmetry in plasma membrane leaflets is well-established, the comprehensive
understanding of this asymmetry in the physicochemical properties and biological function of the
membrane is lacking. Here we report a molecular-level description of the human red blood cell
(RBC) plasma membrane that replicates the experimentally determined composition of the lipid
families that constitute the exoplasmic and cytoplasmic leaflets. Cholesterol exhibits an affinity
for sphingomyelin lipids resulting in a 5:3 distribution between leaflets in favor of the exoplasmic
leaflet (EL) leading to the formation of nanodomains. On the other hand, the cytoplasmic leaflet
(CL) lacks nanodomains due to the presence of fewer saturated lipids. With the facilitation of
cholesterols, EL containing more saturated lipids is more densely packed comparing to CL. We
further illustrated this observation with several characterization methods, including Voronoi
tessellation, lipid order parameter, and leaflet density map. Furthermore, we performed thermal
annealing simulations to study temperature-triggered membrane asymmetry properties.
Interestingly, cholesterols flip between the leaflets at an increasing rate while the overall
distribution maintains the same. We noticed that the membrane lipids can be capable of tolerating
moderate temperature changes from the environment. In summary, fingerprinting the RBC plasma
membrane lipidome elucidates the complex relationships among different lipid families in
conferring asymmetric properties to the membrane.
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3.2 Introduction
Advances in membrane lipidomics have revealed a rich chemical diversity and leaflet
asymmetry in eukaryotic cells. 66-73 These observations contrast to the rudimentary fluid-mosaic
model of cell membranes that depicted the membrane as a simple mixture of lipids that
accommodated membrane proteins. 74-75 Besides being a cell's first line of defense, the plasma
membrane is a highly functional interface where many signal transduction events occur mediated
via the peripheral and membrane-embedded proteins.76-80 The plasma membrane leaflet
asymmetry is evident in various eukaryotic cells—red blood cells (RBCs), platelets, and neuronal
cells.
The lipid diversity manifests in two ways: (i) chemical structure of the lipids—charge, and
type of the headgroups, length of the acyl chains, and the number and location of double bonds in
the acyl chain backbone; and (ii) compositional diversity—the proportion of lipids in membrane
leaflets.81 These variations confer each leaflet its distinct biophysical property to interface with the
cell's external and internal environment. 69-70 Alteration in leaflet composition can lead to a loss in
cell function and even apoptosis.70, 82
A recent study reported human RBC plasma membrane's leaflet asymmetry and distinct
compositions of the exoplasmic and cytosolic leaflets. 83 The results showed that compared to the
cytosolic leaflet (CL), the exoplasmic leaflet (EL) is more densely packed and rich in lipids with
a higher percentage of saturated lipids. In particular, the EL is composed of phosphatidylcholine
(PC), sphingomyelins (SM), and a small percentage of phosphatidylserine (PS) and
phosphatidylethanolamine plasmalogen (PEP). In contrast, the CL has higher lipid head group
diversity, including phosphatidylethanolamine (PE), PEP, PS, PC, SM, and phosphatidylinositols
(PI). Although cholesterol was reported in both leaflets, the experimental analysis did not directly
82

provide the cholesterol distribution. 83 The detailed lipid distribution within the major lipid families
is reproduced in Figure 3-1.

Figure 3-1. RBC plasma membrane composition distribution in exoplasmic leaflet and
cytoplasmic leaflet. Lipids separated by category, phosphatidylcholine (PC, cyan), sphingomyelin
(SM, dark cyan), phosphatidylserine (PS, red), phosphatidylethanolamine (PE, blue),
phosphatidylethanolamine plasmalogen (PEP, yellow), and phosphatidylinositol (PI, orange).
Lipid species annotated as (total number of carbon atoms in the acyl chain):(total number of double
bonds in acyl chains);(total number of hydroxyl groups in the long acyl chain).
Despite the evidence of plasma membrane leaflet asymmetry, a comprehensive
understanding of the RBC membrane leaflet's physicochemical properties and biological function
is lacking. The unique lipid composition of each leaflet impacts the membrane's biophysical
properties: cholesterol distribution (flip-flop rate and domain formation); membrane density (area
per lipid); surface charge (lipid headgroup distribution); membrane protein distribution (protein
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hydrophobic thickness and shape); and membrane protein's post-translational modifications (CL
versus EL).
Several computational studies have focused on the structure and dynamics of model cell
membranes with variable lipid complexities and compositions. 84-101 Ingólfsson et al. modeled an
idealized plasma membrane consisting of 63 different lipid species that were asymmetrically
distributed across the two leaflets. 91 Other computational studies have investigated asymmetric
cholesterol distribution in the lipid bilayers. 102-108 A recent study correlated cholesterol distribution
with the leaflet's lipid order; the more ordered the leaflet, the higher its cholesterol concentration—
the type of lipids in the leaflet influence the cholesterol distribution and the flip-flop rate between
the leaflets.108 The model membranes have been foundational in deciphering molecular level lipidlipid interactions.
However, the human RBC plasma membrane lipidome is more complex than an idealized
model membrane previously investigated by computational techniques. The recently reported
RBC membrane lipidome's unique feature is the highly saturated PC and SM lipids, which
constitute ~56 mol% of the EL.83 The abundance of these lipid acyl chains and their molecular
interplay within the EL and lipids of the opposing CL remains unexplored.
Here, we investigate the structural and compositional diversities in RBC membrane leaflets
using molecular dynamics at the coarse-grained (CG) resolution. We employed the Martini force
field parameters,47, 50, 113 which have been widely used to investigate biomembranes 19, 51, 53-54, 94,
108, 114

and proteins.50-51, 108, 115-121 We modeled a subset of SM, PE, PEP, and PI lipids unavailable

in the Martini force field. The results show the membrane asymmetry in terms of the lipid order
parameters in each membrane leaflet, cholesterol distribution, leaflet densities, and membrane
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thickness. The methods used and the results of the simulations are provided in sections 3.3 and
3.4, respectively.

3.3 Methods
Martini Force Field Parameters. The Martini CG parameters are based on a many-toone mapping scheme, in which four neighboring non-hydrogen atoms are mapped into one CG
bead.47-48, 50, 52, 113 Martini has some flexibility to adopt a three-to-one or five-to-one mapping
scheme, if required, to preserve some properties in the chemical structures. The RBC membrane
constitutes of several lipids (Table S1) with the following lipid families: PC (PIPC, PAPC, POPC,
and DPPC); SM (DPSM, PLSM, and PNSM); PEP (PEP1 and PEP2); PE (POPE, PUPE, and
PEPE); PS (PAPS); and PI (PIP2).
The Martini force field parameters are available for most of the RBC m embrane lipids
(PIPC, PAPC, POPC, DPPC, DPSM, PNSM, POPE, PUPE, PAPS, and CHOL). For the remaining
lipids, the parameters were constructed using the Martini headgroup and acyl chain bead types.
Unlike the available PE lipids, the PEP lipids possess a vinyl-ether linkage at the sn-1 position
instead of an ester linkage and an ester linkage at the sn-2 position,122 for which Martini parameters
had to be developed. The parameter sets for the newly developed lipids—PLSM, PEP1, PEP2,
PEPE, and PIP2 (Table 3-2 – 3-6) are available for download from our research website.
Lipid Membrane. A 30×30 nm2 patch membrane mimicking the human RBC plasma
membrane composition was

constructed in

the CG

presentation using a

locally

modified insane.py script.60 The newly developed lipids are included in this modified insane.py
script. The membrane EL and CL consisted of distinct lipid compositions. The membrane was
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placed in a 30×30×15 nm3 simulation box and solvated with standard Martini water (9:1 of W:WF)

and 150 mM NaCl. The molecular composition of the simulation box is provided in Table 3-7.
CG MD Simulations. The GROMACS 5.1.2 package56 was used for all MD simulations.
The system was energy minimized until the maximum force on any bead was below the tolerance
parameter of 10 kJmol−1nm−1. The minimization was followed by equilibration in the isothermalisochoric (NVT) conditions for 25 ns, followed by a two-step isothermal-isobaric NPT (NPT1 and
NPT2) equilibration for 30 and 45 ns, respectively. Position restraints were used at lipid PO4
headgroup beads in NVT, NPT1, and NPT2 with a force constant set at 100, 10, and 5 kJmol−1nm−2,
respectively. A 20-fs time step was used for the equilibration and production runs. The temperature

was maintained at 300 K for all systems using the v-rescale123 thermostat with τt = 1 ps. A semiisotropic pressure coupling of 1 bar was maintained using Parrinello-Rahman barostat124 with τp =
8 ps. Both the nonbonded van der Waals and the electrostatic interaction cut-offs were set to 1.1
nm. The potential-shift-Verlet algorithm was applied to shift the van der Waals interactions beyond
the cut-off. The Coulombic interactions were calculated using the reaction-field algorithm.
Periodic boundary conditions were applied in all three dimensions. All position restraints were

removed in the production runs. Flat-bottomed position restraints were applied to the phosphate
beads of the lipid at 2.5 nm above and below the membrane with force constant of 1000
kJmol−1nm−2. The simulations were performed in triplicates, each for five microseconds,
determined by the convergence of the mixing parameters (Figures 3-8 – 3-14). Thermal annealing
simulations were performed from 280 K to 320 K with 5 K interval; each temperature step was
equilibrated for 500 ns.
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3.4 Results and Discussion
3.4.1 Plasma membrane lipid families confer distinct physicochemical
properties to the EL and CL leaflets
The physicochemical properties of the RBC membrane were evaluated based on lipid-lipid
interactions among the different lipid families (Figure 3-17). The lateral assembly of a lipid within
the family (self-association) or with other lipid families (co-localization) was determined in two
ways—local area density and lipid mixing parameters. The local area density was computed for
each lipid family in a leaflet and is represented by the Voronoi plots. 125 If the area density of two
or more lipid families coincided in a region, it suggested co-localization. In addition, if the area
density was contiguous over an extended patch of the membrane, it indicated domain formation.
On the other hand, the lipid mixing parameters provided a comparison of a lipid's affinity to
establish self and cross interactions among various lipid types (Section 3.7.1). For example, in a
well-equilibrated, homogenous lipid membrane, each lipid type will have an equal representation
of all other lipids within its interacting distance. Conversely, a domain-forming lipid will exclude
different lipid types from its interaction radius to the greatest extent possible.
The SM and PC families, key lipid families in the RBC membrane’s EL, exhibit a
heterogeneous lipid distribution (Figure 3-15). The SM lipids tend to self-associate and co-localize
with cholesterol to form nanodomains. These nanodomains do not extend more than 3-4 nm and
are separated by PC lipids (Figure 3-2a). The SM’s tendency to form nanodomains is supported
by the mixing parameters analysis. SM lipids have the highest proportion of self-association (44%)
followed by a mixing affinity with cholesterol (30%) and PC (22%). The other lipid families
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collectively represent <4% mixing. The SM concentration in the CL is negligible to form clusters
(Figure 3-2a).

Figure 3-2. Voronoi tessellation of (a) SM, (b) PC, (c) PS, and (d) PEP lipids in the EL (left panel)
and CL (center panel). The lipid density varies from high (darker shades) to low (lighter shades).
The mixing parameters (right panel) of the lipid within its family and with other lipid families is
shown in the donut charts. The name of each reference lipid is in the center of its respective donut.
Lipid families that have low mixing (< 3%) with the reference lipid are omitted for clarity.
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The PC lipids self-associate to a lesser extent than the SM. As a result, the PC lipids in the
EL fill the area not occupied by the SM nanodomains leading to some local clustering (Figure 32b). The PC clustering in the CL is characteristically distinct from the EL; here the PC lipids are
much more dispersed due to the lack of SM nanodomains in the CL and lower mole fraction. The
remaining lipid families in the EL have a less significant contribution to the exterior surface of the
RBC.
The negatively charged PS lipids have a self-associating affinity, but their clustering is not
continuous to form domains (Figure 3-15). The PS lipids have almost equal mixing with PC, PE,
and PEP lipids as indicated by their mixing parameters (Figure 3-2c).
The PE lipids are exclusively in CL and heterogeneously distributed with minimal self-

association or clustering. The PE molecules do not exhibit affinity to any specific lipid family in
the CL (Figure 3-3a). The PEP is a subclass of the PE lipid that shares the same headgroup but has
a vinyl ether linkage for one of its carbon chains. The area density and mixing parameters mimic
the PE lipid properties in the CL (Figure 3-2d). PEP constitutes less than 3% of the EL lipids and
similar to PS, lacking the nanodomain formation in the EL (Figure 3-2d).
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Figure 3-3 Voronoi tessellation of (a) PE and (b) PI lipids in the CL. The lipid density varies from
high (darker shades) to low (lighter shades). The mixing parameters of the lipid within its family
and with other lipid families is shown in the donut charts. The name of each reference lipid is in
the center of its respective donut. Lipid families that have low mixing (< 3%) with the reference
lipid are omitted for clarity.

Besides PE lipids, PI is also exclusive in the CL. The highly charged PI lipids have been
the focus of several computational studies.126-127 The PI lipids are in tiny mole fractions in the CL
and do not exhibit colocalization with any lipid family. A few examples of PI clusters in the
membrane protein interface have been reported.128-129 The PI family forms non-specific
interactions with the membrane lipids, which is evident in the Voronoi plot and the mixing

parameters (Figure 3-3b).
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The results display that human RBC plasma membrane leaflets have very distinct surface

properties. The EL has distinct SM nanodomains while the CL has a near random distribution of
PS, PE, and PEP lipid families.

3.4.2 Membrane cytoplasmic leaflet has lower lipid order than the exoplasmic
leaflet
Membrane asymmetry is reflected in terms of membrane composition. Comparing lipid

orders in EL and CL is another approach to show lipid packing in this asymmetric RBC plasma
membrane. The order parameter, SCD, was generated for the acyl chain beads for each lipid. Within
each leaflet, the cumulative SCD is calculated from the same set of carbon beads (Figure 3-4). The
SCD decreases as the acyl chain beads of interest move from headgroups towards lipid tails,
meaning the farther the carbon bead is located away from the headgroups, the less ordered it gets.
This trend holds true for both leaflets. Overall, EL has a larger SCD and contains more ordered

lipids than the CL, which is consistent with the latest reports.83, 108
After analyzing order parameters from the perspective of position of the carbon beads, we

computed the order parameter of each acyl chain in the lipid molecules (Table 3-8). It is evident
from the order parameters that saturated and unsaturated acyl chains have remarkably different
contribution to a lipids shape and packing in the membrane (Figure 3-16). The box plots of lipids
in EL and CL are shown in Figure 3-5a and Figure 3-5b, respectively. For example, PAPC’s 16:0
acyl chain is much more ordered (0.52±0.258) than the 20:4 (0.13±0.214) chain. There is
remarkable disparity in the median values of the PUPE lipid’s order parameters; the shorter

saturated (16:0) chain is ordered (0.41±0.281), while the longer, unsaturated (22:6) is highly
disordered (0.04±0.196). The PEP1 and PEP2 acyl chains also show differences in the vinyl ester
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linked chain versus the ether linked acyl chain. Interestingly, the saturated DPPC lipid (16:0-16:0),

sequestered in the CL in the plasma membrane, has high order parameters (0.49±0.272 and
0.46±0.274) for both acyl chains. Overall, the boxes in the EL are located higher than those in the
CL, which can be used to reflect that the order parameters of lipids in the EL in general are higher
than those in the CL. This observation is consistent with the profile from Figure 3-4, which again
confirms that lipids in the EL are more ordered.

Figure 3-4 Order parameters of all lipids in EL (black) and CL (red), excluding cholesterols. The
dashed line (gray) indicates the membrane’s mid-plane.
The statistical analysis of the lipid order parameters highlight three important aspects: (a)

the lipids adopt ordered-disordered-ordered layering of the membrane in EL, mid-plane, CL
direction; (b) on average lipids in EL are more ordered than those in CL; (c) between the two acyl
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chains of a lipid, the shorter and saturated acyl chain is more ordered than the longer, unsaturated

acyl chain.

Figure 3-5 Order parameters of all lipids in EL (a) and CL (b) are shown as a box-whisker plot.
Lipid species in (a) from left to right are PIPC, POPC, PAPC, PNSM, PLSM, DPSM, PAPS, and
PEP1. Lipid species in (b) from left to right include PIPC, POPC, DPPC, POPE, PUPE, PEPE,
PEP1, PEP2, DPSM, PAPS, and PIP2. The two acyl chains of a lipid are distinguished by solid
and striped boxes.
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The pairing of short/long, saturated/unsaturated, and charged/zwitterionic lipids along with

asymmetric lipid compositions of the leaflets is critical in unique biophysical properties of the
RBC plasma membrane.

3.4.3 Cholesterol flips between leaflets with preference for the exoplasmic
leaflet
Several simulation studies have focused on evaluating the interaction of cholesterol with

the lipids and the flip-flop dynamics between the membrane leaflets. Analyzing this dynamic
behavior of cholesterol is experimentally challenging due to multiple confounding factors.105, 130131

The use of computational tools can capture the cholesterol flip-flop behavior.102-104, 106-108

Figure 3-6 Quantitative analysis of cholesterol partitioning in the RBC membrane. (a) Number of
cholesterol flips from CL to EL (back), from EL to CL (red), and the total number of flip-flops
(green) as a function of simulation time. (b) Percent cholesterols in EL (black) and in CL (red)
over the five microseconds. (c) Mixing parameters of cholesterol with other lipid families.

In the initial system set-up, cholesterol was distributed equally in each leaflet. In the preequilibrium NVT and NPT stages of the simulation, more molecules of cholesterol flipped from
the CL to the EL than vice-versa. At equilibrium, the rate of cholesterol flip-flop between the
two leaflets reached a stable distribution (Figure 3-6a and 3-6b); the EL and CL cholesterol
distribution is 63±3% and 37±3%, respectively.
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Previous experimental and computational studies have demonstrated the preferred

interaction of cholesterol with the saturated lipids.133 It has been suggested that the interaction
between cholesterol molecules and SM lipids lead to the formation of lipid domains.134-135 The
lipid mixing parameters revealed the lateral association of cholesterol with membrane lipids: SM
(27%), PC (25%), cholesterol (28%), PS (7%), PE (6%), PEP (6%), and PI (1%), as shown in
Figure 3-6c. The preferential association of cholesterol with the SM and PC lipids is established
within the first few microseconds of the simulations and remains unchanged after equilibration.

The triplicate simulation runs show the same cholesterol lipid mixing trends. Thus, cholesterol
localization occurs disproportionately in the SM-enriched EL.

3.4.4 Exoplasmic and cytosolic leaflets differ as temperature changes
We performed thermal annealing simulations to further characterize membrane asymmetry

properties. First, EL and CL have different area per lipid values regardless of temperature. Due to
variations in shapes and surface areas of different lipids, the EL has a smaller area per lipid (0.45±
0.04 lipids nm−2) relative to the CL (0.55± 0.03 lipids nm−2), which is consistent with earlier
reports. The change in the area per lipid versus temperature in 280-320 K was evaluated. The area
per lipid values increased linearly for both leaflets (Figure 3-7a); in the meantime, the rate of
increase of area per lipid for EL is nearly identical to that of CL. On the other hand, as the

temperature increases, lipids become more fluid and dynamic, which leads to the lateral expansion
of the membrane patch and the transverse reduction in membrane bilayer thickness (Figure 3-7b).
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The observations match well with each other, which show that the entire membrane stretch and

become thinner in response to increasing temperature.

Figure 3-7 Variations in the area per lipid of EL (black) and CL (red), and thickness as a function
of temperature in (a) and (b), respectively. (c) Cholesterol distribution between EL (black) and CL
(red) as temperature increases from 280K to 320K. (d) Cholesterol flip-flop rate over the same
range of temperatures.
Furthermore, we characterized the cholesterol dynamic behavior in terms of temperature.
We noticed that the cholesterol distribution between leaflets remains the same (63±3% in EL and
37±3% in CL) as temperature spans from 280K to 320K (Figure 3-7c), which can be attributed to
the unchanged lipid composition in each leaflet. This characterization can be used to prove that
the major determinant of cholesterol distribution between asymmetric membrane leaflets is the
respective composition, especially considering several key lipid families, such as SM and PC
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lipids containing saturated acyl chains with higher affinity to cholesterols. However, we did
observe that despite the constant cholesterol distribution in EL and CL, there are more
cholesterols flipping between leaflets as the temperature increases (Figure 3-7d). It is obvious
that the rate of cholesterol flip-flop is increasing exponentially from 2 µs −1nm−2 to 11 µs−1nm−2
at 280K to 320K, respectively. Therefore, increasing the temperature has a large impact on
cholesterols flipping more rapidly even though the overall distribution remains unchanged
between asymmetric leaflets.

3.5 Conclusions
We report a detailed molecular description of the human RBC plasma membrane that
replicates the experimentally determined lipid composition of each of the two asymmetric
membrane leaflets. Interestingly, cholesterol has a high binding affinity for SMs that results in an
asymmetric 5:3 distribution of cholesterol in favor of the exoplasmic leaflet. The SM and PC lipids
, and cholesterol lateral associate to form nanodomains in the exoplasmic leaflet. In contrast, the
cytoplasmic leaflet has a near-random distribution of the PC, PS, PE, PEP, and PI families. All
lipid families have the highest mixing parameter with the lipids of their species. As temperature
increases, membrane bilayer becomes thinner and the area of the membrane patch stretches,
resulting in larger area per lipid in both EL and CL. In addition to the increasing temperature, the
rate of cholesterol flip-flop inreases while maintaining a constant distribution between the
asymmetric leaflets. Fingerprinting the plasma membrane lipidome is pivotal in elucidating how
cells exchange metabolites, transfer signals, and facilitate protein assembly.
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3.6 Supporting Information
3.6.1 Methods and Analysis
Analyses were performed using multiple, in-house developed python scripts. Molecular
visualization and graphics were generated using VMD and PyMOL.
Mixing parameter. The mixing parameter of membrane lipids is calculated as 𝑝𝑖𝑗 =

𝐶𝑖𝑗
∑𝐶𝑖𝑘

, where

𝑝𝑖𝑗 is the mixing parameter between lipid 𝑖 and lipid 𝑗, 𝐶𝑖𝑗 is the number of contacts made by lipid
𝑖 with lipid 𝑗, and ∑𝐶𝑖𝑘 is the total contacts made by lipid 𝑖 with all surrounding lipids, including
itself. A contact is defined to have formed between two lipid molecules if the distance between a
lipid species and the reference lipid is within a 1.1 nm cut-off.
Order parameter. The order parameter of lipid acyl chain is calculated from 2H NMR as 𝑆CD =
3cos2 𝜃−1

ۃ

2

ۄ, where 𝑆CD is the order parameter between the carbon-hydrogen (C−D) bond, 𝜃 is the

angle between the C−D bond vector and a reference axis, which is the membrane normal 𝑥, 𝑦, 𝑧 =
0, 0, 1. The angular brackets determine that order parameters are weighted over time. Two types

of order parameters were evaluated in this work, in viewpoint of carbon beads, order parameter
was calculated between every two adjacent carbon beads and averaged over lipids of the
exoplasmic leaflet (EL) and the cytoplasmic leaflet (CL), respectively. For the other purpose of
analysis, each entire lipid acyl chain was calculated with one order parameter generated, averaging
over lipids of the same type in EL and CL, respectively.
Density analysis. The number density of CG beads in EL and CL were calculated using the
MDAnalysis library. The density profile is approximated by discretizing the simulation box into
areas of 1𝑛𝑚 × 1𝑛𝑚 and calculating the local number density in each region.
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Voronoi tessellation. For each lipid type (PSM, PC, PI, PS, PE, PEP), the (x, y) coordinates of
their C1, D1 and T1 beads on either of the leaflets were obtained using MDAnalysis package.
These coordinates were used as input points to compute Voronoi diagram using scipy python
package. The vertices of each Voronoi region were acquired from the scipy Voronoi object, and
these vertices were used to calculate the polygon area using the “shoelace formula”. The individual
regions of the Voronoi diagrams were then colored based on their respective areas.
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3.6.2 Supporting Tables
Table 3-1 Lipid names, corresponding head groups and tails, and assigned four letter names
Lipid names
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine
1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine
1-palmitoyl-2-palmitoyl-d31-sn-glycero-3-phosphocholine
N-Palmitoylsphingomyelin
Lysosphingomyelin
Neutral sphingomyelinase
1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine
1-(1-Enyl-stearoyl)-2-adrenoyl-sn-glycero-3phosphoethanolamine
1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3phosphoethanolamine
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3phosphoethanolamine
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-arachidonoyl
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
1-stearoyl-2-adrenoyl-sn-glycero-3-phosphoinositol
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Corresponding
head groups and
tails
PC 16:0-18:2
PC 16:0-20:4
PC18:0-18:1
PC 16:0-16:0
SM 34:1;2
SM 42:1;2
SM 42:2;2
PS 18:0-20:4
PE-O 18:1-20:4

Four
letter
names
PIPC
PAPC
POPC
DPPC
DPSM
PLSM
PNSM
PAPS
PEP1

PE-O 18:2-20:4

PEP2

PE 16:0-22:6

PUPE

PE 18:1-20:4
PE 16:0-18:1
PIP2 18:1-20:4

PEPE
POPE
PIP2

Table 3-2 MARTINI CG beads and parameters for PEP1
Bond
1-2
2-3
3-4
3-5
5-6
6-7
7-8
8-9
4-10
10-11
11-12
12-13

Angle
2-3-4
2-3-5
3-5-6
5-6-7
6-7-8
7-8-9
4-10-11
10-11-12
11-12-13

R(nm)
0.47
0.47
0.37
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
θ (deg)
120
180
100
100
100
120
180
120
180

Kbond (kJ mol−1 nm−2)
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
Kangle (kJ mol−1)
25
25
10
10
10
45
25
45
25
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Table 3-3 MARTINI CG beads and parameters for PEP2
Bond
1-2
2-3
3-4
3-5
5-6
6-7
7-8
8-9
4-10
10-11
11-12
12-13

Angle
2-3-4
2-3-5
3-5-6
5-6-7
6-7-8
7-8-9
4-10-11
10-11-12
11-12-13

R(nm)
0.47
0.47
0.37
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
θ (deg)
120
180
100
100
100
120
180
100
120

Kbond (kJ mol−1 nm−2)
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
Kangle (kJ mol−1)
25
25
10
10
10
45
25
10
45
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Table 3-4 MARTINI CG beads and parameters for PEPE
Bond
1-2
2-3
3-4
3-5
5-6
6-7
7-8
8-9
4-10
10-11
11-12
12-13

Angle
2-3-4
2-3-5
3-5-6
5-6-7
6-7-8
7-8-9
4-10-11
10-11-12
11-12-13

R(nm)
0.47
0.47
0.37
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
θ (deg)
120
180
100
100
100
120
180
120
180

Kbond (kJ mol−1 nm−2)
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
Kangle (kJ mol−1)
25
25
10
10
10
45
25
45
25
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Table 3-5. MARTINI CG beads and parameters for PLSM

Bond
1-2
2-3
3-4
3-5
5-6
6-7
4-8
8-9
9-10
10-11
11-12
12-13

Angle
2-3-4
2-3-5
3-5-6
5-6-7
4-8-9
8-9-10
9-10-11
10-11-12
11-12-13

R(nm)
0.47
0.47
0.37
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
θ (deg)
120
180
180
180
180
180
180
180
180

Kbond (kJ mol−1 nm−2)
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
Kangle (kJ mol−1)
25
25
45
25
25
25
25
25
25
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Table 3-6. MARTINI CG beads and parameters for PIP2

Bond
1-2
1-3
2-3
2-5
2-6
1-5
3-6
5-6
1-4
4-7
7-8
7-9
9-10
10-11
11-12
12-13
8-14
14-15
15-16
16-17

Angle
1-4-7
7-9-10
9-10-11
10-11-12
11-12-13
8-14-15
14-15-16
15-16-17

R(nm)
0.40
0.40
0.40
0.30
0.35
0.40
0.31
0.60
0.35
0.47
0.37
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
0.47
θ (deg)
140
100
100
100
120
180
120
180

Kbond (kJ mol−1 nm−2)
30000
30000
30000
25000
30000
25000
30000
25000
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
1250
Kangle (kJ mol−1)
25
10
10
10
45
25
45
25
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Table 3-7 Composition of RBC plasma membrane simulation system
Molecule/Ion
PIPC
PNSM
PLSM
PAPC
POPC
DPSM
PAPS
PEP1
PIP2
PUPE
PEPE
POPE
PEP2
DPPC
CHOL
W
WF
Na+
Cl−
Total lipids
excluding
CHOL

EL
250
164
141
93
118
211
22
47
—
—
—
—
—
—
705

CL
160
—
—
—
68
22
251
160
45
137
68
45
45
45
710

System

Total

65703
7300
1053
555
1046

1046
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Table 3-8 Lipid order parameters (SCD) separated by exoplasmic and cytoplasmic leaflets and
fatty acid tail

Lipid

Acyl chain

PIPC
DPSM
PLSM
PNSM
PAPC
POPC
PAPS
PIP2
PEP1
PUPE
PEPE
POPE
PEP2
DPPC

16:0-18:2
34:1;2
42:1;2
42:2;2
16:0-20:4
18:0-18:1
18:0-20:4
18:0-22:4
18:1-22:4
16:0-22:6
18:1-20:4
16:0-18:1
18:2-20:4
16:0-16:0

Exoplasmic Leaflet
Tail 1 (Left)
Tail 2 (Right)
Mean
Mean
SCD
SCD
0.53±0.255
0.26±0.267
0.71±0.256
0.63±0.221
0.70±0.265
0.51±0.215
0.71±0.259
0.47±0.187
0.52±0.258
0.13±0.214
0.55±0.252
0.47±0.257
0.52±0.250
0.29±0.326
—
—
0.38±0.265
0.14±0.218
—
—
—
—
—
—
—
—
—
—
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Cytoplasmic Leaflet
Tail 1 (Left)
Tail 2 (Right)
Mean
Mean
SCD
SCD
0.42±0.280
0.21±0.249
0.44±0.277
0.30±0.348
—
—
—
—
—
—
0.42±0.280
0.35±0.262
0.40±0.280
0.10±0.201
0.32±0.259
0.13±0.199
0.30±0.265
0.11±0.202
0.41±0.281
0.04±0.196
0.31±0.264
0.11±0.203
0.41±0.280
0.34±0.264
0.20±0.244
0.11±0.207
0.49±0.272
0.46±0.274

3.6.3 Supporting Figures

Figure 3-8 Mixing parameter profile of PC

108

Figure 3-9 Mixing parameter profile of CHOL
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Figure 3-10 Mixing parameter profile of SM
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Figure 3-11 Mixing parameter profile of PS
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Figure 3-8 Mixing parameter profile of PEP
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Figure 3-9 Mixing parameter profile of PE
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Figure 3-10 Mixing parameter profile of PI
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Figure 3-11 The cross-sectional profiles of equilibrated RBC plasma membrane. (a) PC, red; (b)
SM, blue; (c) PS, orange; (d) PE, purple; (e) PEP, green; (f) PI, cyan;(g) cholesterol, gray; and (h)
all lipid types. For clarity, all lipid headgroups (black) are shown
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Figure 3-12 Representative lipid image after simulation (a) PIPC, (b) DPSM, (c) PNSM, (d)
PLSM, (e) POPC, (f) PAPC, (g) PAPS, (h) PEP1, (i) POPE, (j) PUPE, (k) PEPE, (l) PEP2, (m)
DPPC, and (n) PIP2. Coarse-grained bead types are denoted as saturated carbon (dark gray),
unsaturated carbon (light gray), NC3 (dark blue), PO4 (pink), GL1 and GL2 (green), AM1 and
AM2 (cyan), CNO (light blue), C1, C2, and C3 (orange), and P1 and P2 (purple).
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Figure 3-17 Mixing parameter (%) of each lipid with other lipid families in the membrane. The
color in each row displays lowest (blue) to highest (red) lipid contacts.
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CHAPTER 4.
NON-CANONICAL LIPOPROTEINS WITH
PROGRAMMABLE ASSEMBLY AND
ARCHITECTURE
Reprint with permission from “Hossain, M. S.; Maller, C.; Dai, Y.; Nangia, S.; Mozhdehi, D. Noncanonical lipoproteins with programmable assembly and architecture. Chem. Commun., 2020, 56,
10281.
DOI: 10.1039/D0CC03271A” Copyright The Royal Society of Chemistry 2020.
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4.1 Abstract
The substrate promiscuity of an acyltransferase is leveraged to synthesize artificial
lipoproteins bearing a non-canonical PTM (ncPTM). The non-canonical functionality of these
lipoproteins results in a distinctive hysteretic assembly—absent from the canonical lipoproteins—
and is used to prepare hybrid multiblock materials with precise and programmable patterns of
amphiphilicity. This study demonstrates the promise of expanding the repertoire of PTMs for the
development of nanomaterials with a unique assembly and function.

4.2 Introduction
The disordered regions on polypeptide chains contribute significantly to the properties of
natural biomaterials and inspire the design of intrinsically disordered peptide-polymers (IDPPs)
for mimicking natural biomaterials. Contrary to common strategies of IDPPs assembly, posttranslational modifications (PTMs) are conducted to control the configuration of proteins.
The application of PTMs in material science is a rare attempt. In this project, non-canonical
PTM (ncPTM) is used by Mozhdehi lab at Syracuse University to develop recombinant
nanomaterials with controlled hierarchical assembly. In comparison with the traditional canonical
PTM modified IDPP with myristic acid (M), ncPTM uses the artificial lipid, 12-azidododecanoic
acid (ADA), which shows distinctive temperature-triggered emergent assembly that is absent in
M-IDPP. We developed an in-silico model from the molecular-scale perspective to explain the
differences in the macromolecular assembly of ADA-IDPP compared to M-IDPP, which can
provide insights in designing novel lipoproteins.
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4.3 Methods
The molecular structure of M-peptide and ADA-peptide molecules were built in two-steps.
First, the three-dimensional structure of the recognition peptide (GLYASKLFSNL) was
determined using the I-TASSER1 webserver. In the second step, the M and ADA lipid tails were
added to the glycine residue of the peptide using the CHARMM-GUI2 webserver. The individual
M-peptide and ADA-peptide structures were equilibrated at 300 K using the CHARMM36 allatom force field available within the CHARMM-GUI workspace.
The equilibrated structures were used to construct two explicitly solvated systems
containing: (i) 15 molecules of M-peptide and (ii) 15 molecules of ADA-peptide using CHARMMGUI Builder.2 Each system contained 150 mM NaCl solution and TIP3P water molecules in a
cubic box with a box length of 10 nm. The systems were energy minimized and equilibrated at T
= 300 K in the isothermal-isochoric (NVT) and at P = 1 bar in isothermal-isobaric (NPT) ensemble
constraints in the CHARMM-GUI workflow. The equilibrated output from these runs was used to
study self-assembly behavior.
The self-assembly molecular dynamics simulations were performed using the GROMACS
2019.4 simulation package.3 The M-peptide and ADA-peptide molecules and ions were modeled
using the CHARMM36 all-atom force field.4 Water was modeled using TIP3P. 5 The NPT
production runs were run for 400 ns using 2 fs timestep. The temperature was maintained at 303.15
K using the Nose-Hoover thermostat 6 with τt = 1.0 ps. The pressure was maintained at 1 bar using
isotropic coupling with Parrinello-Rahman barostat 7 with τP = 5 ps and compressibility of 4.5 x
10−5 bar-1. Periodic boundary conditions were applied in all three dimensions. The nonbonded
van der Waals interactions were calculated using a cutoff of 1.2 nm. The long-range electrostatic
interactions were studied with particle mesh Ewald (PME) algorithm at a 1.2 nm cutoff. 8 Further,
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thermal annealing simulations were performed for both systems over 280−360 K temperature
range (280, 290, 300, 310, 320, 330, 340, 350, and 360 K) over a total simulation time of 400 ns.
Analyses of the results from thermal annealing simulations, including radius of gyration (Rg) and
solvent accessible surface area (SASA), were performed using GROMACS built -in utilities.
Molecular visualization was performed using VMD software.9

4.4 Results and Discussion

Figure 4-1 Result of in silico self-assembly of M–peptide and ADA–peptide molecules using allatom molecular dynamics simulations. a) Snapshot of 15 M–peptide molecules showing core-shell
structure with myristoyl chains (green) in the core and peptides (purple) forming the shell at 40
°C. b) Snapshot of 15 ADA–peptide aggregate with ADA chains (green) and terminal azide (blue)
on the surface of aggregate along with the peptides (purple) at 40 °C. c) The variation in the radius
of gyration (Rg) of the M–peptide (black) and ADA–peptide (red) aggregates over 30–60 °C. d)
The variation in the solvent accessible surface area (SASA) of the M–peptide (black) ADA–
peptide (red) aggregates over 30–60 °C.

We developed an in-silico model to explain the differences in the self-assembly of ADAIDPP compared to canonical lipoprotein (M-IDPP)—hysteresis and non-equilibrium assembly
into fibers— and to bridge our understanding from a molecular structure level to macromolecular
assembly. Given the 99.5% similarity between the two lipoproteins, we confined our atomistic
simulations to the N-terminal amphiphilic region (lipid–recognition sequence peptide); the single
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letter amino acid sequence of the recognition peptide used is GLYASKLFSNL. The aggregation

of the M–peptides occurs via the hydrophobic interactions of the myristoyl chains (shown in green)
that form a micellar core while the peptides (purple) form the shell (Figure 4-1a). In contrast, in
ADA–peptide assembly, the charged azide (-N3) groups (blue beads in Figure 4-1b) are
hydrophilic and remain solvent-exposed, preventing efficient packing and formation of a lipid
core. Further, the ADA–peptide aggregate has a consistently higher radius of gyration (Rg) and
solvent accessible surface area (SASA) compared to M–peptide aggregate (Figure 4-1c,d) over the

30–60 °C temperature range. The Combination of computational and experimental results show
for the first time that despite the increased hydrophilicity of the ADA (compared to the canonical
lipid), it can drive the self-assembly of the recombinant lipoprotein into micelles.

4.5 Conclusions
In summary, the well-documented substrate-promiscuity of lipidation machinery has been
extensively leveraged in the field of chemical biology. 10-12 We applied this strategy to design novel
lipoproteins with emergent material properties such as a stimuli-responsive shape-shifting
nanomorphology. We foresee several opportunities for the design of dynamic nano-biomaterials
in this untapped chemical design space. For example, a programmable morphological change from
nanoparticles to fibers can be used to simultaneously release encapsulated cargo and provide a
scaffold for cell-adhesion and growth. Non-canonical lipids can also be used as chemical handles
for structural elaboration and synthesis of hybrid materials with a unique and precise amphiphilic
pattern. These hybrid systems can be programmed to assemble into complex 2D and 3D
morphologies to form materials with unique optical and mechanical properties.
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CHAPTER 5.
CONCLUSIONS AND FUTURE WORK
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5.1 Conclusions
In our research, we have adopted Multiscale MD modeling, which combines the all-atom
(AA) and the coarse-grained (CG) resolutions, along with other advanced MD techniques, to apply

computational simulations to the biomolecular field of study and provide molecular insights that
are undetectable via currently available experimental methods. In this work, we described the
development and validation of a computational method to accelerate the antibiotic discovery
pipeline, we performed comprehensive investigation of plasma membrane lipidome asymmetry of
human red blood cells to unveil physicochemical perperties and biological functions, we
collaborated with an experimental group to understand variations in self-assembly of canonical

and non-canonical lipoproteins at a molecular-level for inspiring macro-scale design of novel
biomaterials.
In Chapter 2, we report the development of a new computational screening platform
(CLASP) that is designed to accelerate the antibiotic discovery process. The CLASP outputs
comprehensive thermodynamic and kinetic data, which includes free energy profile, energy
barrier, translocation rate constant, contact analysis of the molecule with the pore-lining residues,
orientation analysis of the molecule within the porin, and the overall mechanism of the antibiotic
uptake. In this first application of CLASP, we demonstrate the translocation profile of six well-

established antibiotics from the carbapenem family through P. Aeruginosa‘s OccD3 channel. The
results show excellent agreement with the barrier heights, the key residues, and the translocation
rates of the drug molecules. We were able to identify critical pore-lining residues in the OccD
channel that provide steric gating. Mutation of these residues to less bulky groups enhanced the
predicted rates.
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In Chapter 3, we report a detailed molecular description of the human RBC plasma
membrane that replicates the experimentally determined lipid composition of each of the two
asymmetric membrane leaflets. We demonstrated distinct physicochemical properties to the
exoplasmic and cytoplasmic leaflets conferred by plasma membrane lipid families. We
characterized the membrane asymmetry by studying lipid mixing parameters and order parameters,
cholesterol flip-flop dynamics, membrane thickness and area per lipid. Fingerprinting the plasma
membrane lipidome is pivotal in elucidating how cells exchange metabolites, transfer signals, and
facilitate protein assembly.
In Chapter 4, we developed in-silico models of canonical and non-canonical posttranslational modified intrinsically disordered peptide-polymers. We characterized temperaturetriggered self-assembly of natural and artificial lipoproteins via thermal annealing atomistic
simulations. Agreement between computational and experimental results reinforced the robustness
of computational modeling and simulation, which bridges the understanding between micro- to
macro-scale self-assembly phenomenon and provides insights in designing novel nanobiomaterials with unique physical and chemical properties.
In summary, the physics-driven computational simulation method in conjunction of
enhanced sampling technique, multiscale modeling, and other supportive computational tools and
high performance computing resources are becoming a robust engine and a necessity in
understanding biological processes at molecular-level and solve scaled-up real life problems.
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5.2 Future Work
For the ongoing CLASP project, we are focusing on the study of small molecule
translocation through another major family of Outer membrane Carboxylate Channel (Occ) from
P. aeruginosa, the OccK subfamily, which is distinct from OccD subfamily by phylogenetic
analysis.1 The porin size of OccK channels are substantially larger than those of OccD subfamily
and are less selective for substrates. 2 We have some preliminary results at this stage. Figure 5-1
shows the visual representation of homology modeled and well equilibrated structures of OccK18. We plan to conduct a systematic comparison between different OccK porins, and with OccD
subfamily porins. We expect to provide further knowledge to the free energy profile and interaction
pattern between drug molecules and porin residues.
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Figure 5-1 Homology modeled P. aeruginosa porin structures displayed in front and top view. (a)
OccK1, (b) OccK2, (c) OccK3, (d) OccK4, (e) OccK5, (f) OccK6, (g) OccK7, and (h) OccK8. The
porin surface is displayed as a transparent shadow.
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On the other hand, the major limitation and the potential challenge for the application of
CLASP is its heavy dependency on molecular database, which may either be unavailable or
incompatible with the current CLASP algorithm. We envision to establish a database of
experimentally solved and homology modeled membrane proteins embedded in biological
membrane lipid systems. Here is a few features we would like to achieve as enhancements for the
current CLASP platform:
•

We would like to develop a graphical user interface for CLASP so that it can be freely
distributed and serve as a robust engine in screening and identifying highly permeable
antibiotic candidates.

•

In the meantime, we would like to establish more well-equilibrated protein inserted
membrane systems at both all-atom and coarse-grained models to ensure they are ready
for use at different resolutions.

•

Ultimately, we expect to collaborate with industry to publish CLASP as a crucial step to
state-of-the-art high-throughput virtual screening method to identify drug candidates.
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